Mexico Financial Markets News
Sign up for free!
Get instant access to all of our market news and analysis with our free REST API.
Latest news
Live response for past 24 hours
{
"meta": {
"found": 520,
"returned": 10,
"limit": 10,
"page": 1
},
"data": [
{
"uuid": "71b65cae-9c0c-4e37-8e31-390d60ed3c4c",
"title": "Elevance Health, Inc. (ELV): Did This Health Insurance Stock Get a Buy Rating from Analysts?",
"description": "We recently compiled a list of the 10 Best Health Insurance Stocks to Buy. In this article, we are going to take a look at where Elevance Health, Inc.",
"keywords": "",
"snippet": "We recently compiled a list of the 10 Best Health Insurance Stocks to Buy. In this article, we are going to take a look at where Elevance Health, Inc. (NYSE:ELV...",
"url": "https://www.insidermonkey.com/blog/elevance-health-inc-elv-did-this-health-insurance-stock-get-a-buy-rating-from-analysts-1326745/",
"image_url": "https://d2gr5kl7dt2z3t.cloudfront.net/blog/wp-content/uploads/2023/09/20061241/ELV-insidermonkey-1695204759756.jpg",
"language": "en",
"published_at": "2024-07-27T02:40:22.000000Z",
"source": "insidermonkey.com",
"relevance_score": null,
"entities": [
{
"symbol": "BLK.MX",
"name": "BlackRock, Inc.",
"exchange": null,
"exchange_long": null,
"country": "mx",
"type": "equity",
"industry": "Financial Services",
"match_score": 11.531286,
"sentiment_score": 0.6369,
"highlights": [
{
"highlight": "On another front, <em>BlackRock</em>, <em>Inc</em>. projects that the healthcare sector will have the highest 12-month forward earnings growth across all sectors on a year-on-year basis, with sales growth trailing only the consumer discretionary and information technology sectors.",
"sentiment": 0.6369,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "ANTM.MX",
"name": "Anthem, Inc.",
"exchange": null,
"exchange_long": null,
"country": "mx",
"type": "equity",
"industry": "Healthcare",
"match_score": 12.743676,
"sentiment_score": 0.6908,
"highlights": [
{
"highlight": "(NYSE:ELV)\n\nNumber of Hedge Fund Holders: 79\n\nFormerly known as <em>Anthem</em>, <em>Inc</em>., Elevance Health, Inc. (NYSE:ELV) is a health benefits company operating in the United States through its subsidiaries. The company manages Blue Cross and Blue Shield plans in 14 states and holds licenses to sell health insurance nationwide.",
"sentiment": 0.6908,
"highlighted_in": "main_text"
}
]
}
],
"similar": [
{
"uuid": "253d7c86-a6fd-4728-986c-b38aa8e5873c",
"title": "Humana Inc. (HUM): Street Analysts are Bullish on This Health Insurance Stock Now",
"description": "We recently compiled a list of the 10 Best Health Insurance Stocks to Buy. In this article, we are going to take a look at where Humana Inc.",
"keywords": "",
"snippet": "We recently compiled a list of the 10 Best Health Insurance Stocks to Buy. In this article, we are going to take a look at where Humana Inc. (NYSE:HUM) stands a...",
"url": "https://www.insidermonkey.com/blog/humana-inc-hum-street-analysts-are-bullish-on-this-health-insurance-stock-now-1326742/",
"image_url": "https://d2gr5kl7dt2z3t.cloudfront.net/blog/wp-content/uploads/2023/09/20133031/HUM-insidermonkey-1695231029118.jpg",
"language": "en",
"published_at": "2024-07-27T02:35:15.000000Z",
"source": "insidermonkey.com",
"relevance_score": null,
"entities": [
{
"symbol": "BLK.MX",
"name": "BlackRock, Inc.",
"exchange": null,
"exchange_long": null,
"country": "mx",
"type": "equity",
"industry": "Financial Services",
"match_score": 10.797828,
"sentiment_score": 0.6369,
"highlights": [
{
"highlight": "On another front, <em>BlackRock</em>, <em>Inc</em>. projects that the healthcare sector will have the highest 12-month forward earnings growth across all sectors on a year-on-year basis, with sales growth trailing only the consumer discretionary and information technology sectors.",
"sentiment": 0.6369,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "HUM.MX",
"name": "Humana Inc.",
"exchange": null,
"exchange_long": null,
"country": "mx",
"type": "equity",
"industry": "Healthcare",
"match_score": 42.702778,
"sentiment_score": 0.171729,
"highlights": [
{
"highlight": "In this article, we are going to take a look at where <em>Humana</em> <em>Inc</em>. (NYSE:HUM) stands against the other health insurance stocks.\n\nThe Healthcare Market: What does the future hold?\n\n2023 posed significant challenges for the healthcare sector as investors adjusted their portfolios to adapt to a higher interest rate environment.",
"sentiment": 0.6249,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Humana</em> <em>Inc</em>. (NYSE:HUM)\n\nNumber of Hedge Fund Holders: 74\n\n<em>Humana</em> <em>Inc</em>. (NYSE:HUM) is dedicated to enhancing health and well-being by providing healthcare benefits to its medical and specialty members.",
"sentiment": 0.7096,
"highlighted_in": "main_text"
},
{
"highlight": "Cantor Fitzgerald recently adjusted its price target for <em>Humana</em> <em>Inc</em>. (NYSE:HUM) to $360 from the previous target of $391 set in April, while maintaining a Neutral rating on the stock. This revision follows Humana’s first-quarter earnings report, which surpassed expected financial metrics.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Humana</em> <em>Inc</em>. (NYSE:HUM)’s medical loss ratio (MLR), a critical measure of the amount spent on medical claims relative to the insurance premiums collected, was 89.3%, slightly higher than the consensus of 88.9%.",
"sentiment": -0.5574,
"highlighted_in": "main_text"
},
{
"highlight": "Cantor Fitzgerald analysts pointed out that although <em>Humana</em> <em>Inc</em>. (NYSE:HUM) has maintained its full-year MLR at 90% and its EPS forecast at approximately $16, there remains some uncertainty about the new guidance for 2025.\n\nAccording to Insider Monkey, 30 out of the 919 hedge funds tracked reported owning stock in <em>Humana</em> <em>Inc</em>.",
"sentiment": -0.34,
"highlighted_in": "main_text"
},
{
"highlight": "Diamond Hill Large Cap Strategy stated the following regarding <em>Humana</em> <em>Inc</em>. (NYSE:HUM) in its first quarter 2024 investor letter:\n\n“Among our bottom Q1 contributors were real estate investment trusts (REITs) Extra Space Storage and SBA Communications, as well as <em>Humana</em> <em>Inc</em>. (NYSE:HUM).",
"sentiment": 0.765,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Humana</em> <em>Inc</em>. (HUM): Street Analysts are Bullish on This Health Insurance Stock Now",
"sentiment": 0,
"highlighted_in": "title"
}
]
},
{
"symbol": "BLK",
"name": "BlackRock, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Financial Services",
"match_score": 10.797673,
"sentiment_score": 0.6369,
"highlights": [
{
"highlight": "On another front, <em>BlackRock</em>, <em>Inc</em>. projects that the healthcare sector will have the highest 12-month forward earnings growth across all sectors on a year-on-year basis, with sales growth trailing only the consumer discretionary and information technology sectors.",
"sentiment": 0.6369,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "HUM",
"name": "Humana Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 62.567753,
"sentiment_score": 0.237063,
"highlights": [
{
"highlight": "In this article, we are going to take a look at where <em>Humana</em> <em>Inc</em>. (<em>NYSE:HUM</em>) stands against the other health insurance stocks.\n\nThe Healthcare Market: What does the future hold?\n\n2023 posed significant challenges for the healthcare sector as investors adjusted their portfolios to adapt to a higher interest rate environment.",
"sentiment": 0.6249,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Humana</em> <em>Inc</em>. (<em>NYSE:HUM</em>)\n\nNumber of Hedge Fund Holders: 74\n\n<em>Humana</em> <em>Inc</em>. (<em>NYSE:HUM</em>) is dedicated to enhancing health and well-being by providing healthcare benefits to its medical and specialty members.",
"sentiment": 0.7096,
"highlighted_in": "main_text"
},
{
"highlight": "Cantor Fitzgerald recently adjusted its price target for <em>Humana</em> <em>Inc</em>. (<em>NYSE:HUM</em>) to $360 from the previous target of $391 set in April, while maintaining a Neutral rating on the stock. This revision follows Humana’s first-quarter earnings report, which surpassed expected financial metrics.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Humana</em> <em>Inc</em>. (<em>NYSE:HUM</em>)’s medical loss ratio (MLR), a critical measure of the amount spent on medical claims relative to the insurance premiums collected, was 89.3%, slightly higher than the consensus of 88.9%.",
"sentiment": -0.5574,
"highlighted_in": "main_text"
},
{
"highlight": "Cantor Fitzgerald analysts pointed out that although <em>Humana</em> <em>Inc</em>. (<em>NYSE:HUM</em>) has maintained its full-year MLR at 90% and its EPS forecast at approximately $16, there remains some uncertainty about the new guidance for 2025.\n\nAccording to Insider Monkey, 30 out of the 919 hedge funds tracked reported owning stock in <em>Humana</em> <em>Inc</em>.",
"sentiment": -0.34,
"highlighted_in": "main_text"
},
{
"highlight": "(<em>NYSE:HUM</em>) as of Q1 2024. Among the top hedge fund investors in the company, Citadel Asset Management held a notable stake valued at over $372.4 million.\n\nDiamond Hill Large Cap Strategy stated the following regarding <em>Humana</em> <em>Inc</em>.",
"sentiment": 0.8225,
"highlighted_in": "main_text"
},
{
"highlight": "(<em>NYSE:HUM</em>) in its first quarter 2024 investor letter:\n\n“Among our bottom Q1 contributors were real estate investment trusts (REITs) Extra Space Storage and SBA Communications, as well as <em>Humana</em> <em>Inc</em>. (<em>NYSE:HUM</em>).",
"sentiment": 0.6369,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Humana</em> <em>Inc</em>. (HUM): Street Analysts are Bullish on This Health Insurance Stock Now",
"sentiment": 0,
"highlighted_in": "title"
}
]
},
{
"symbol": "0J6Z.L",
"name": "Humana Inc.",
"exchange": null,
"exchange_long": null,
"country": "gb",
"type": "equity",
"industry": "N/A",
"match_score": 69.86478,
"sentiment_score": 0.36351,
"highlights": [
{
"highlight": "In this article, we are going to take a look at where <em>Humana</em> <em>Inc</em>. (NYSE:HUM) stands against the other health insurance stocks.\n\nThe Healthcare Market: What does the future hold?\n\n2023 posed significant challenges for the healthcare sector as investors adjusted their portfolios to adapt to a higher interest rate environment.",
"sentiment": 0.6249,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Humana</em> <em>Inc</em>. (NYSE:HUM)\n\nNumber of Hedge Fund Holders: 74\n\n<em>Humana</em> <em>Inc</em>. (NYSE:HUM) is dedicated to enhancing health and well-being by providing healthcare benefits to its medical and specialty members.",
"sentiment": 0.7096,
"highlighted_in": "main_text"
},
{
"highlight": "Cantor Fitzgerald recently adjusted its price target for <em>Humana</em> <em>Inc</em>. (NYSE:HUM) to $360 from the previous target of $391 set in April, while maintaining a Neutral rating on the stock. This revision follows Humana’s first-quarter earnings report, which surpassed expected financial metrics.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Humana</em> reported an EPS of $7.23 for Q1 2024, exceeding the FactSet consensus of $6.12. The company’s revenue reached $29.6 billion, surpassing the expected $28.5 billion. <em>Humana</em> <em>Inc</em>.",
"sentiment": 0.1027,
"highlighted_in": "main_text"
},
{
"highlight": "Cantor Fitzgerald analysts pointed out that although <em>Humana</em> <em>Inc</em>. (NYSE:HUM) has maintained its full-year MLR at 90% and its EPS forecast at approximately $16, there remains some uncertainty about the new guidance for 2025.\n\nAccording to Insider Monkey, 30 out of the 919 hedge funds tracked reported owning stock in <em>Humana</em> <em>Inc</em>.",
"sentiment": -0.34,
"highlighted_in": "main_text"
},
{
"highlight": "Diamond Hill Large Cap Strategy stated the following regarding <em>Humana</em> <em>Inc</em>. (NYSE:HUM) in its first quarter 2024 investor letter:\n\n“Among our bottom Q1 contributors were real estate investment trusts (REITs) Extra Space Storage and SBA Communications, as well as <em>Humana</em> <em>Inc</em>. (NYSE:HUM).",
"sentiment": 0.765,
"highlighted_in": "main_text"
},
{
"highlight": "Shares of health insurance company <em>Humana</em> were meaningfully pressured in late 2023 against a backdrop of accelerating medical costs among its Medicare population, weighing on health plan profitability.",
"sentiment": 0.34,
"highlighted_in": "main_text"
},
{
"highlight": "Further, since Medicare Advantage plan pricing is set in June of each year for the following year, <em>Humana</em> is unable to offset increased medical costs with higher pricing — which in turn pressured shares in Q1.",
"sentiment": 0.5267,
"highlighted_in": "main_text"
},
{
"highlight": "Nevertheless, we anticipate <em>Humana</em> will be able to improve margins over the next several years and maintain our conviction in our position.”\n\nOverall HUM ranks 4th on our list of the best health insurance stocks to buy. You can visit 10 Best Health Insurance Stocks to Buy to see the other health insurance stocks that are on hedge funds’ radar.",
"sentiment": 0.9062,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Humana</em> <em>Inc</em>. (HUM): Street Analysts are Bullish on This Health Insurance Stock Now",
"sentiment": 0,
"highlighted_in": "title"
}
]
},
{
"symbol": "0QZZ.L",
"name": "BlackRock, Inc.",
"exchange": null,
"exchange_long": null,
"country": "gb",
"type": "equity",
"industry": "N/A",
"match_score": 10.797423,
"sentiment_score": 0.6369,
"highlights": [
{
"highlight": "On another front, <em>BlackRock</em>, <em>Inc</em>. projects that the healthcare sector will have the highest 12-month forward earnings growth across all sectors on a year-on-year basis, with sales growth trailing only the consumer discretionary and information technology sectors.",
"sentiment": 0.6369,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "BLQA.DE",
"name": "BlackRock, Inc.",
"exchange": null,
"exchange_long": null,
"country": "de",
"type": "equity",
"industry": "Financial Services",
"match_score": 10.796847,
"sentiment_score": 0.6369,
"highlights": [
{
"highlight": "On another front, <em>BlackRock</em>, <em>Inc</em>. projects that the healthcare sector will have the highest 12-month forward earnings growth across all sectors on a year-on-year basis, with sales growth trailing only the consumer discretionary and information technology sectors.",
"sentiment": 0.6369,
"highlighted_in": "main_text"
}
]
}
]
},
{
"uuid": "b3167d85-401c-4091-94b6-ceee2871eae6",
"title": "Why Are Hedge Funds Bullish on The Cigna Group (CI) Right Now?",
"description": "We recently compiled a list of the 10 Best Health Insurance Stocks to Buy.",
"keywords": "",
"snippet": "We recently compiled a list of the 10 Best Health Insurance Stocks to Buy. In this article, we are going to take a look at where The Cigna Group (NYSE:CI) stand...",
"url": "https://www.insidermonkey.com/blog/why-are-hedge-funds-bullish-on-the-cigna-group-ci-right-now-1326736/",
"image_url": "https://d2gr5kl7dt2z3t.cloudfront.net/blog/wp-content/uploads/2023/09/20090459/CI-insidermonkey-1695215097592.jpg",
"language": "en",
"published_at": "2024-07-27T02:25:46.000000Z",
"source": "insidermonkey.com",
"relevance_score": null,
"entities": [
{
"symbol": "BLK.MX",
"name": "BlackRock, Inc.",
"exchange": null,
"exchange_long": null,
"country": "mx",
"type": "equity",
"industry": "Financial Services",
"match_score": 10.797828,
"sentiment_score": 0.6369,
"highlights": [
{
"highlight": "On another front, <em>BlackRock</em>, <em>Inc</em>. projects that the healthcare sector will have the highest 12-month forward earnings growth across all sectors on a year-on-year basis, with sales growth trailing only the consumer discretionary and information technology sectors.",
"sentiment": 0.6369,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "BLK",
"name": "BlackRock, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Financial Services",
"match_score": 10.797673,
"sentiment_score": 0.6369,
"highlights": [
{
"highlight": "On another front, <em>BlackRock</em>, <em>Inc</em>. projects that the healthcare sector will have the highest 12-month forward earnings growth across all sectors on a year-on-year basis, with sales growth trailing only the consumer discretionary and information technology sectors.",
"sentiment": 0.6369,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "CI",
"name": "Cigna Corporation",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 52.06619,
"sentiment_score": 0.622036,
"highlights": [
{
"highlight": "In this article, we are going to take a look at where The <em>Cigna</em> Group (<em>NYSE:CI</em>) stands against the other health insurance stocks.\n\nThe Healthcare Market: What does the future hold?\n\n2023 posed significant challenges for the healthcare sector as investors adjusted their portfolios to adapt to a higher interest rate environment.",
"sentiment": 0.6249,
"highlighted_in": "main_text"
},
{
"highlight": "The <em>Cigna</em> Group (<em>NYSE:CI</em>)\n\nNumber of Hedge Fund Holders: 61\n\nThe <em>Cigna</em> Group (<em>NYSE:CI</em>) and its subsidiaries specialize in offering insurance and related products and services in the United States. The company also provides pharmacy benefits, home delivery pharmacy, and specialty pharmacy distribution services.",
"sentiment": 0.6908,
"highlighted_in": "main_text"
},
{
"highlight": "The <em>Cigna</em> Group (<em>NYSE:CI</em>) reported a notable first-quarter, with sales of $57.26 billion, a 23% year-over-year increase, surpassing the consensus estimate of $55.47 billion. This growth was primarily driven by substantial gains in Evernorth Health Services, reflecting multiple large client acquisitions.",
"sentiment": 0.7964,
"highlighted_in": "main_text"
},
{
"highlight": "Adjusted income from operations rose 16% to $1.88 billion, with strong contributions from both <em>Cigna</em> Healthcare and Evernorth Health Services. <em>Cigna</em> Healthcare sales increased 4% year-over-year to $13.3 billion, reflecting premium rate adjustments.",
"sentiment": 0.6597,
"highlighted_in": "main_text"
},
{
"highlight": "Following The <em>Cigna</em> Group (<em>NYSE:CI</em>)’s strong first-quarter financial results, RBC Capital Markets slightly raised its price target for CI shares to $384 from $383, while maintaining an Outperform rating.",
"sentiment": 0.6705,
"highlighted_in": "main_text"
},
{
"highlight": "RBC’s assessment was also influenced by Cigna’s recent investor day, during which the company raised its long-term growth targets to a range of 10-14%, a projection RBC believes is justified based on The <em>Cigna</em> Group (<em>NYSE:CI</em>)’s current performance and trajectory.",
"sentiment": 0.6486,
"highlighted_in": "main_text"
},
{
"highlight": "Hedge fund sentiment towards The <em>Cigna</em> Group (<em>NYSE:CI</em>) appears positive, with 61 funds holding significant stakes in the company as of Q1 2024. The largest position is held by Glenview Capital, which owns 1.47 million shares valued at $534.3 million.",
"sentiment": 0.8591,
"highlighted_in": "main_text"
},
{
"highlight": "Here is what Davis New York Venture Fund has to say about The <em>Cigna</em> Group (<em>NYSE:CI</em>) in its Q3 2023 investor letter:\n\n“In the attractive healthcare sector, we look beyond the obvious to identify businesses that simultaneously have exposure to this growth industry and also trade at low prices.",
"sentiment": 0.2023,
"highlighted_in": "main_text"
},
{
"highlight": "We’re especially drawn to companies like <em>Cigna</em> Group, whose products or services play a part in helping to mitigate healthcare’s constantly rising costs. The healthcare industry has been a growing part of the U.S. economy for decades.",
"sentiment": 0.7783,
"highlighted_in": "main_text"
},
{
"highlight": "As a result, we have positions in <em>Cigna</em> Group, a well-regarded provider of managed care.\n\nOverall CI ranks 6th on our list of the best health insurance stocks to buy. You can visit 10 Best Health Insurance Stocks to Buy to see the other health insurance stocks that are on hedge funds’ radar.",
"sentiment": 0.9118,
"highlighted_in": "main_text"
},
{
"highlight": "Why Are Hedge Funds Bullish on The <em>Cigna</em> Group (CI) Right Now?",
"sentiment": 0,
"highlighted_in": "title"
}
]
},
{
"symbol": "0QZZ.L",
"name": "BlackRock, Inc.",
"exchange": null,
"exchange_long": null,
"country": "gb",
"type": "equity",
"industry": "N/A",
"match_score": 10.797423,
"sentiment_score": 0.6369,
"highlights": [
{
"highlight": "On another front, <em>BlackRock</em>, <em>Inc</em>. projects that the healthcare sector will have the highest 12-month forward earnings growth across all sectors on a year-on-year basis, with sales growth trailing only the consumer discretionary and information technology sectors.",
"sentiment": 0.6369,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "BLQA.DE",
"name": "BlackRock, Inc.",
"exchange": null,
"exchange_long": null,
"country": "de",
"type": "equity",
"industry": "Financial Services",
"match_score": 10.796847,
"sentiment_score": 0.6369,
"highlights": [
{
"highlight": "On another front, <em>BlackRock</em>, <em>Inc</em>. projects that the healthcare sector will have the highest 12-month forward earnings growth across all sectors on a year-on-year basis, with sales growth trailing only the consumer discretionary and information technology sectors.",
"sentiment": 0.6369,
"highlighted_in": "main_text"
}
]
}
]
},
{
"uuid": "ad544621-8f51-489b-82bc-43d4cb901bb5",
"title": "Centene Corporation (CNC): Do Hedge Funds Recommend This Health Insurance Stock Right Now?",
"description": "We recently compiled a list of the 10 Best Health Insurance Stocks to Buy.",
"keywords": "",
"snippet": "We recently compiled a list of the 10 Best Health Insurance Stocks to Buy. In this article, we are going to take a look at where Centene Corporation (NYSE:CNC) ...",
"url": "https://www.insidermonkey.com/blog/centene-corporation-cnc-do-hedge-funds-recommend-this-health-insurance-stock-right-now-1326731/",
"image_url": "https://d2gr5kl7dt2z3t.cloudfront.net/blog/wp-content/uploads/2023/09/22051242/CNC-insidermonkey-1695373960033.jpg",
"language": "en",
"published_at": "2024-07-27T02:19:31.000000Z",
"source": "insidermonkey.com",
"relevance_score": null,
"entities": [
{
"symbol": "BLK.MX",
"name": "BlackRock, Inc.",
"exchange": null,
"exchange_long": null,
"country": "mx",
"type": "equity",
"industry": "Financial Services",
"match_score": 10.797828,
"sentiment_score": 0.6369,
"highlights": [
{
"highlight": "On another front, <em>BlackRock</em>, <em>Inc</em>. projects that the healthcare sector will have the highest 12-month forward earnings growth across all sectors on a year-on-year basis, with sales growth trailing only the consumer discretionary and information technology sectors.",
"sentiment": 0.6369,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "CNC.MX",
"name": "Centene Corporation",
"exchange": null,
"exchange_long": null,
"country": "mx",
"type": "equity",
"industry": "Healthcare",
"match_score": 86.08524,
"sentiment_score": 0.62656,
"highlights": [
{
"highlight": "In this article, we are going to take a look at where <em>Centene</em> <em>Corporation</em> (NYSE:CNC) stands against the other health insurance stocks.\n\nThe Healthcare Market: What does the future hold?\n\n2023 posed significant challenges for the healthcare sector as investors adjusted their portfolios to adapt to a higher interest rate environment.",
"sentiment": 0.6249,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Centene</em> <em>Corporation</em> (NYSE:CNC)\n\nNumber of Hedge Fund Holders: 56\n\n<em>Centene</em> <em>Corporation</em> (NYSE:CNC), based in St. Louis, Missouri, is a publicly traded managed care firm that acts as an intermediary for both government-sponsored and privately insured healthcare programs.",
"sentiment": 0.5423,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Centene</em> <em>Corporation</em> (NYSE:CNC) reported first-quarter profits of $1.1 billion, driven by an increase in membership and premium revenue, thanks to a significant rise in Obamacare enrollment.",
"sentiment": 0.836,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Centene</em> <em>Corporation</em> (NYSE:CNC) also raised its 2024 diluted earnings per share guidance floor to more than $5.94 and its adjusted diluted EPS guidance floor to more than $6.80.",
"sentiment": 0.296,
"highlighted_in": "main_text"
},
{
"highlight": "Among the largest hedge fund shareholders of <em>Centene</em> <em>Corporation</em> (NYSE:CNC) is Harris Associates, holding shares valued at $1.33 billion.",
"sentiment": 0.6249,
"highlighted_in": "main_text"
},
{
"highlight": "Oakmark Global Fund stated the following regarding <em>Centene</em> <em>Corporation</em> (NYSE:CNC) in its first quarter 2024 investor letter:\n\n“<em>Centene</em> <em>Corporation</em> (NYSE:CNC) is a large health insurer specializing in three major government-sponsored programs: Medicaid, Marketplace and Medicare Advantage.",
"sentiment": 0.25,
"highlighted_in": "main_text"
},
{
"highlight": "In Medicaid, states are steadily outsourcing their programs to managed care companies like <em>Centene</em> to help reduce costs and improve care quality. Managed Medicaid penetration has increased meaningfully over the past two decades, and we expect further gains over time.",
"sentiment": 0.9517,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Centene</em> holds the top market share in both of these programs and is well-positioned to capitalize on their continued growth. Finally, in Centene’s Medicare Advantage business, past missteps will result in losses next year, but we believe <em>Centene</em> can turn its Medicare Advantage segment around and generate positive earnings in the next few years.",
"sentiment": 0.8705,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Centene</em> currently trades for about 9x our estimate of normal earnings power, which we believe is a compelling value for a business that generates healthy returns on capital and is capable of growing EPS at a low double-digit rate.”\n\nOverall CNC ranks 7th on our list of the best health insurance stocks to buy.",
"sentiment": 0.9081,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Centene</em> <em>Corporation</em> (CNC): Do Hedge Funds Recommend This Health Insurance Stock Right Now?",
"sentiment": 0.3612,
"highlighted_in": "title"
}
]
},
{
"symbol": "BLK",
"name": "BlackRock, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Financial Services",
"match_score": 10.797673,
"sentiment_score": 0.6369,
"highlights": [
{
"highlight": "On another front, <em>BlackRock</em>, <em>Inc</em>. projects that the healthcare sector will have the highest 12-month forward earnings growth across all sectors on a year-on-year basis, with sales growth trailing only the consumer discretionary and information technology sectors.",
"sentiment": 0.6369,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "CNC",
"name": "Centene Corporation",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 105.72368,
"sentiment_score": 0.62656,
"highlights": [
{
"highlight": "In this article, we are going to take a look at where <em>Centene</em> <em>Corporation</em> (<em>NYSE:CNC</em>) stands against the other health insurance stocks.\n\nThe Healthcare Market: What does the future hold?\n\n2023 posed significant challenges for the healthcare sector as investors adjusted their portfolios to adapt to a higher interest rate environment.",
"sentiment": 0.6249,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Centene</em> <em>Corporation</em> (<em>NYSE:CNC</em>)\n\nNumber of Hedge Fund Holders: 56\n\n<em>Centene</em> <em>Corporation</em> (<em>NYSE:CNC</em>), based in St. Louis, Missouri, is a publicly traded managed care firm that acts as an intermediary for both government-sponsored and privately insured healthcare programs.",
"sentiment": 0.5423,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Centene</em> <em>Corporation</em> (<em>NYSE:CNC</em>) reported first-quarter profits of $1.1 billion, driven by an increase in membership and premium revenue, thanks to a significant rise in Obamacare enrollment.",
"sentiment": 0.836,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Centene</em> <em>Corporation</em> (<em>NYSE:CNC</em>) also raised its 2024 diluted earnings per share guidance floor to more than $5.94 and its adjusted diluted EPS guidance floor to more than $6.80.",
"sentiment": 0.296,
"highlighted_in": "main_text"
},
{
"highlight": "Among the largest hedge fund shareholders of <em>Centene</em> <em>Corporation</em> (<em>NYSE:CNC</em>) is Harris Associates, holding shares valued at $1.33 billion.",
"sentiment": 0.6249,
"highlighted_in": "main_text"
},
{
"highlight": "Oakmark Global Fund stated the following regarding <em>Centene</em> <em>Corporation</em> (<em>NYSE:CNC</em>) in its first quarter 2024 investor letter:\n\n“<em>Centene</em> <em>Corporation</em> (<em>NYSE:CNC</em>) is a large health insurer specializing in three major government-sponsored programs: Medicaid, Marketplace and Medicare Advantage.",
"sentiment": 0.25,
"highlighted_in": "main_text"
},
{
"highlight": "In Medicaid, states are steadily outsourcing their programs to managed care companies like <em>Centene</em> to help reduce costs and improve care quality. Managed Medicaid penetration has increased meaningfully over the past two decades, and we expect further gains over time.",
"sentiment": 0.9517,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Centene</em> holds the top market share in both of these programs and is well-positioned to capitalize on their continued growth. Finally, in Centene’s Medicare Advantage business, past missteps will result in losses next year, but we believe <em>Centene</em> can turn its Medicare Advantage segment around and generate positive earnings in the next few years.",
"sentiment": 0.8705,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Centene</em> currently trades for about 9x our estimate of normal earnings power, which we believe is a compelling value for a business that generates healthy returns on capital and is capable of growing EPS at a low double-digit rate.”\n\nOverall CNC ranks 7th on our list of the best health insurance stocks to buy.",
"sentiment": 0.9081,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Centene</em> <em>Corporation</em> (CNC): Do Hedge Funds Recommend This Health Insurance Stock Right Now?",
"sentiment": 0.3612,
"highlighted_in": "title"
}
]
},
{
"symbol": "0HVB.L",
"name": "Centene Corporation",
"exchange": null,
"exchange_long": null,
"country": "gb",
"type": "equity",
"industry": "N/A",
"match_score": 86.06985,
"sentiment_score": 0.62656,
"highlights": [
{
"highlight": "In this article, we are going to take a look at where <em>Centene</em> <em>Corporation</em> (NYSE:CNC) stands against the other health insurance stocks.\n\nThe Healthcare Market: What does the future hold?\n\n2023 posed significant challenges for the healthcare sector as investors adjusted their portfolios to adapt to a higher interest rate environment.",
"sentiment": 0.6249,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Centene</em> <em>Corporation</em> (NYSE:CNC)\n\nNumber of Hedge Fund Holders: 56\n\n<em>Centene</em> <em>Corporation</em> (NYSE:CNC), based in St. Louis, Missouri, is a publicly traded managed care firm that acts as an intermediary for both government-sponsored and privately insured healthcare programs.",
"sentiment": 0.5423,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Centene</em> <em>Corporation</em> (NYSE:CNC) reported first-quarter profits of $1.1 billion, driven by an increase in membership and premium revenue, thanks to a significant rise in Obamacare enrollment.",
"sentiment": 0.836,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Centene</em> <em>Corporation</em> (NYSE:CNC) also raised its 2024 diluted earnings per share guidance floor to more than $5.94 and its adjusted diluted EPS guidance floor to more than $6.80.",
"sentiment": 0.296,
"highlighted_in": "main_text"
},
{
"highlight": "Among the largest hedge fund shareholders of <em>Centene</em> <em>Corporation</em> (NYSE:CNC) is Harris Associates, holding shares valued at $1.33 billion.",
"sentiment": 0.6249,
"highlighted_in": "main_text"
},
{
"highlight": "Oakmark Global Fund stated the following regarding <em>Centene</em> <em>Corporation</em> (NYSE:CNC) in its first quarter 2024 investor letter:\n\n“<em>Centene</em> <em>Corporation</em> (NYSE:CNC) is a large health insurer specializing in three major government-sponsored programs: Medicaid, Marketplace and Medicare Advantage.",
"sentiment": 0.25,
"highlighted_in": "main_text"
},
{
"highlight": "In Medicaid, states are steadily outsourcing their programs to managed care companies like <em>Centene</em> to help reduce costs and improve care quality. Managed Medicaid penetration has increased meaningfully over the past two decades, and we expect further gains over time.",
"sentiment": 0.9517,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Centene</em> holds the top market share in both of these programs and is well-positioned to capitalize on their continued growth. Finally, in Centene’s Medicare Advantage business, past missteps will result in losses next year, but we believe <em>Centene</em> can turn its Medicare Advantage segment around and generate positive earnings in the next few years.",
"sentiment": 0.8705,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Centene</em> currently trades for about 9x our estimate of normal earnings power, which we believe is a compelling value for a business that generates healthy returns on capital and is capable of growing EPS at a low double-digit rate.”\n\nOverall CNC ranks 7th on our list of the best health insurance stocks to buy.",
"sentiment": 0.9081,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Centene</em> <em>Corporation</em> (CNC): Do Hedge Funds Recommend This Health Insurance Stock Right Now?",
"sentiment": 0.3612,
"highlighted_in": "title"
}
]
},
{
"symbol": "0QZZ.L",
"name": "BlackRock, Inc.",
"exchange": null,
"exchange_long": null,
"country": "gb",
"type": "equity",
"industry": "N/A",
"match_score": 10.797423,
"sentiment_score": 0.6369,
"highlights": [
{
"highlight": "On another front, <em>BlackRock</em>, <em>Inc</em>. projects that the healthcare sector will have the highest 12-month forward earnings growth across all sectors on a year-on-year basis, with sales growth trailing only the consumer discretionary and information technology sectors.",
"sentiment": 0.6369,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "C1NC34.SA",
"name": "Centene Corporation",
"exchange": null,
"exchange_long": null,
"country": "br",
"type": "equity",
"industry": "Healthcare",
"match_score": 86.12451,
"sentiment_score": 0.62656,
"highlights": [
{
"highlight": "In this article, we are going to take a look at where <em>Centene</em> <em>Corporation</em> (NYSE:CNC) stands against the other health insurance stocks.\n\nThe Healthcare Market: What does the future hold?\n\n2023 posed significant challenges for the healthcare sector as investors adjusted their portfolios to adapt to a higher interest rate environment.",
"sentiment": 0.6249,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Centene</em> <em>Corporation</em> (NYSE:CNC)\n\nNumber of Hedge Fund Holders: 56\n\n<em>Centene</em> <em>Corporation</em> (NYSE:CNC), based in St. Louis, Missouri, is a publicly traded managed care firm that acts as an intermediary for both government-sponsored and privately insured healthcare programs.",
"sentiment": 0.5423,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Centene</em> <em>Corporation</em> (NYSE:CNC) reported first-quarter profits of $1.1 billion, driven by an increase in membership and premium revenue, thanks to a significant rise in Obamacare enrollment.",
"sentiment": 0.836,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Centene</em> <em>Corporation</em> (NYSE:CNC) also raised its 2024 diluted earnings per share guidance floor to more than $5.94 and its adjusted diluted EPS guidance floor to more than $6.80.",
"sentiment": 0.296,
"highlighted_in": "main_text"
},
{
"highlight": "Among the largest hedge fund shareholders of <em>Centene</em> <em>Corporation</em> (NYSE:CNC) is Harris Associates, holding shares valued at $1.33 billion.",
"sentiment": 0.6249,
"highlighted_in": "main_text"
},
{
"highlight": "Oakmark Global Fund stated the following regarding <em>Centene</em> <em>Corporation</em> (NYSE:CNC) in its first quarter 2024 investor letter:\n\n“<em>Centene</em> <em>Corporation</em> (NYSE:CNC) is a large health insurer specializing in three major government-sponsored programs: Medicaid, Marketplace and Medicare Advantage.",
"sentiment": 0.25,
"highlighted_in": "main_text"
},
{
"highlight": "In Medicaid, states are steadily outsourcing their programs to managed care companies like <em>Centene</em> to help reduce costs and improve care quality. Managed Medicaid penetration has increased meaningfully over the past two decades, and we expect further gains over time.",
"sentiment": 0.9517,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Centene</em> holds the top market share in both of these programs and is well-positioned to capitalize on their continued growth. Finally, in Centene’s Medicare Advantage business, past missteps will result in losses next year, but we believe <em>Centene</em> can turn its Medicare Advantage segment around and generate positive earnings in the next few years.",
"sentiment": 0.8705,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Centene</em> currently trades for about 9x our estimate of normal earnings power, which we believe is a compelling value for a business that generates healthy returns on capital and is capable of growing EPS at a low double-digit rate.”\n\nOverall CNC ranks 7th on our list of the best health insurance stocks to buy.",
"sentiment": 0.9081,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Centene</em> <em>Corporation</em> (CNC): Do Hedge Funds Recommend This Health Insurance Stock Right Now?",
"sentiment": 0.3612,
"highlighted_in": "title"
}
]
},
{
"symbol": "BLQA.DE",
"name": "BlackRock, Inc.",
"exchange": null,
"exchange_long": null,
"country": "de",
"type": "equity",
"industry": "Financial Services",
"match_score": 10.796847,
"sentiment_score": 0.6369,
"highlights": [
{
"highlight": "On another front, <em>BlackRock</em>, <em>Inc</em>. projects that the healthcare sector will have the highest 12-month forward earnings growth across all sectors on a year-on-year basis, with sales growth trailing only the consumer discretionary and information technology sectors.",
"sentiment": 0.6369,
"highlighted_in": "main_text"
}
]
}
]
},
{
"uuid": "d3e59955-ca95-49cd-aa2b-783494d5390e",
"title": "Is CVS Health Corporation (CVS) the Best Health Insurance Stock to Buy Now?",
"description": "We recently compiled a list of the 10 Best Health Insurance Stocks to Buy.",
"keywords": "",
"snippet": "We recently compiled a list of the 10 Best Health Insurance Stocks to Buy. In this article, we are going to take a look at where CVS Health Corporation (NYSE:CV...",
"url": "https://www.insidermonkey.com/blog/is-cvs-health-corporation-cvs-the-best-health-insurance-stock-to-buy-now-1326727/",
"image_url": "https://d2gr5kl7dt2z3t.cloudfront.net/blog/wp-content/uploads/2023/09/21041848/CVS-insidermonkey-1695284326686.jpg",
"language": "en",
"published_at": "2024-07-27T02:13:00.000000Z",
"source": "insidermonkey.com",
"relevance_score": null,
"entities": [
{
"symbol": "BLK.MX",
"name": "BlackRock, Inc.",
"exchange": null,
"exchange_long": null,
"country": "mx",
"type": "equity",
"industry": "Financial Services",
"match_score": 10.797828,
"sentiment_score": 0.6369,
"highlights": [
{
"highlight": "On another front, <em>BlackRock</em>, <em>Inc</em>. projects that the healthcare sector will have the highest 12-month forward earnings growth across all sectors on a year-on-year basis, with sales growth trailing only the consumer discretionary and information technology sectors.",
"sentiment": 0.6369,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "CVS.MX",
"name": "CVS Health Corporation",
"exchange": null,
"exchange_long": null,
"country": "mx",
"type": "equity",
"industry": "Healthcare",
"match_score": 122.734985,
"sentiment_score": 0.3522,
"highlights": [
{
"highlight": "In this article, we are going to take a look at where <em>CVS</em> <em>Health</em> <em>Corporation</em> (NYSE:CVS) stands against the other health insurance stocks.\n\nThe Healthcare Market: What does the future hold?\n\n2023 posed significant challenges for the healthcare sector as investors adjusted their portfolios to adapt to a higher interest rate environment.",
"sentiment": 0.6249,
"highlighted_in": "main_text"
},
{
"highlight": "<em>CVS</em> <em>Health</em> <em>Corporation</em> (NYSE:CVS)\n\nNumber of Hedge Fund Holders: 54\n\n<em>CVS</em> <em>Health</em> <em>Corporation</em> (NYSE:CVS) is a U.S.-based healthcare enterprise that manages an extensive network of retail pharmacies and clinics across the country.",
"sentiment": 0.0772,
"highlighted_in": "main_text"
},
{
"highlight": "In early May, Argus revised its stock price target for <em>CVS</em> <em>Health</em> <em>Corporation</em> (NYSE:CVS), lowering it to $80 from the previous $100 while maintaining a Buy rating. This adjustment followed CVS Health’s first-quarter earnings for 2024, which fell short of market expectations and led the company to revise its guidance downward.",
"sentiment": -0.25,
"highlighted_in": "main_text"
},
{
"highlight": "Additionally, on May 23, <em>CVS</em> <em>Health</em> <em>Corporation</em> (NYSE:CVS) saw its shares decline by as much as 3% following an unconfirmed report that the company was seeking a private equity (PE) partnership to expand its Oak Street Health platform.",
"sentiment": 0.4588,
"highlighted_in": "main_text"
},
{
"highlight": "According to the report, <em>CVS</em> <em>Health</em> <em>Corporation</em> (NYSE:CVS) may pursue a partnership similar to Humana’s with Welsh Carson, where CVS would initially take a minority interest in new clinics with an option to purchase once they are established.",
"sentiment": 0.4588,
"highlighted_in": "main_text"
},
{
"highlight": "Ariel Global Fund stated the following regarding <em>CVS</em> <em>Health</em> <em>Corporation</em> (NYSE:CVS) in its first quarter 2024 investor letter:\n\n“We bought American healthcare company, <em>CVS</em> <em>Health</em> <em>Corporation</em> (NYSE:CVS), following recent concerns related to potential new laws affecting Pharmacy Benefit Managers (PBMs)—intermediaries that negotiate drug prices between",
"sentiment": 0.4588,
"highlighted_in": "main_text"
},
{
"highlight": "Is <em>CVS</em> <em>Health</em> <em>Corporation</em> (CVS) the Best Health Insurance Stock to Buy Now?",
"sentiment": 0.6369,
"highlighted_in": "title"
}
]
},
{
"symbol": "BLK",
"name": "BlackRock, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Financial Services",
"match_score": 10.797673,
"sentiment_score": 0.6369,
"highlights": [
{
"highlight": "On another front, <em>BlackRock</em>, <em>Inc</em>. projects that the healthcare sector will have the highest 12-month forward earnings growth across all sectors on a year-on-year basis, with sales growth trailing only the consumer discretionary and information technology sectors.",
"sentiment": 0.6369,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "CVS",
"name": "CVS Health Corporation",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 141.06207,
"sentiment_score": 0.3522,
"highlights": [
{
"highlight": "In this article, we are going to take a look at where <em>CVS</em> <em>Health</em> <em>Corporation</em> (<em>NYSE:CVS</em>) stands against the other health insurance stocks.\n\nThe Healthcare Market: What does the future hold?\n\n2023 posed significant challenges for the healthcare sector as investors adjusted their portfolios to adapt to a higher interest rate environment.",
"sentiment": 0.6249,
"highlighted_in": "main_text"
},
{
"highlight": "<em>CVS</em> <em>Health</em> <em>Corporation</em> (<em>NYSE:CVS</em>)\n\nNumber of Hedge Fund Holders: 54\n\n<em>CVS</em> <em>Health</em> <em>Corporation</em> (<em>NYSE:CVS</em>) is a U.S.-based healthcare enterprise that manages an extensive network of retail pharmacies and clinics across the country.",
"sentiment": 0.0772,
"highlighted_in": "main_text"
},
{
"highlight": "In early May, Argus revised its stock price target for <em>CVS</em> <em>Health</em> <em>Corporation</em> (<em>NYSE:CVS</em>), lowering it to $80 from the previous $100 while maintaining a Buy rating. This adjustment followed CVS Health’s first-quarter earnings for 2024, which fell short of market expectations and led the company to revise its guidance downward.",
"sentiment": -0.25,
"highlighted_in": "main_text"
},
{
"highlight": "Additionally, on May 23, <em>CVS</em> <em>Health</em> <em>Corporation</em> (<em>NYSE:CVS</em>) saw its shares decline by as much as 3% following an unconfirmed report that the company was seeking a private equity (PE) partnership to expand its Oak Street Health platform.",
"sentiment": 0.4588,
"highlighted_in": "main_text"
},
{
"highlight": "According to the report, <em>CVS</em> <em>Health</em> <em>Corporation</em> (<em>NYSE:CVS</em>) may pursue a partnership similar to Humana’s with Welsh Carson, where CVS would initially take a minority interest in new clinics with an option to purchase once they are established.",
"sentiment": 0.4588,
"highlighted_in": "main_text"
},
{
"highlight": "Ariel Global Fund stated the following regarding <em>CVS</em> <em>Health</em> <em>Corporation</em> (<em>NYSE:CVS</em>) in its first quarter 2024 investor letter:\n\n“We bought American healthcare company, <em>CVS</em> <em>Health</em> <em>Corporation</em> (<em>NYSE:CVS</em>), following recent concerns related to potential new laws affecting Pharmacy Benefit Managers (PBMs)—intermediaries that negotiate drug prices between",
"sentiment": 0.4588,
"highlighted_in": "main_text"
},
{
"highlight": "Is <em>CVS</em> <em>Health</em> <em>Corporation</em> (CVS) the Best Health Insurance Stock to Buy Now?",
"sentiment": 0.6369,
"highlighted_in": "title"
}
]
},
{
"symbol": "0HRS.L",
"name": "CVS Health Corporation",
"exchange": null,
"exchange_long": null,
"country": "gb",
"type": "equity",
"industry": "N/A",
"match_score": 122.726105,
"sentiment_score": 0.3522,
"highlights": [
{
"highlight": "In this article, we are going to take a look at where <em>CVS</em> <em>Health</em> <em>Corporation</em> (NYSE:CVS) stands against the other health insurance stocks.\n\nThe Healthcare Market: What does the future hold?\n\n2023 posed significant challenges for the healthcare sector as investors adjusted their portfolios to adapt to a higher interest rate environment.",
"sentiment": 0.6249,
"highlighted_in": "main_text"
},
{
"highlight": "<em>CVS</em> <em>Health</em> <em>Corporation</em> (NYSE:CVS)\n\nNumber of Hedge Fund Holders: 54\n\n<em>CVS</em> <em>Health</em> <em>Corporation</em> (NYSE:CVS) is a U.S.-based healthcare enterprise that manages an extensive network of retail pharmacies and clinics across the country.",
"sentiment": 0.0772,
"highlighted_in": "main_text"
},
{
"highlight": "In early May, Argus revised its stock price target for <em>CVS</em> <em>Health</em> <em>Corporation</em> (NYSE:CVS), lowering it to $80 from the previous $100 while maintaining a Buy rating. This adjustment followed CVS Health’s first-quarter earnings for 2024, which fell short of market expectations and led the company to revise its guidance downward.",
"sentiment": -0.25,
"highlighted_in": "main_text"
},
{
"highlight": "Additionally, on May 23, <em>CVS</em> <em>Health</em> <em>Corporation</em> (NYSE:CVS) saw its shares decline by as much as 3% following an unconfirmed report that the company was seeking a private equity (PE) partnership to expand its Oak Street Health platform.",
"sentiment": 0.4588,
"highlighted_in": "main_text"
},
{
"highlight": "According to the report, <em>CVS</em> <em>Health</em> <em>Corporation</em> (NYSE:CVS) may pursue a partnership similar to Humana’s with Welsh Carson, where CVS would initially take a minority interest in new clinics with an option to purchase once they are established.",
"sentiment": 0.4588,
"highlighted_in": "main_text"
},
{
"highlight": "Ariel Global Fund stated the following regarding <em>CVS</em> <em>Health</em> <em>Corporation</em> (NYSE:CVS) in its first quarter 2024 investor letter:\n\n“We bought American healthcare company, <em>CVS</em> <em>Health</em> <em>Corporation</em> (NYSE:CVS), following recent concerns related to potential new laws affecting Pharmacy Benefit Managers (PBMs)—intermediaries that negotiate drug prices between",
"sentiment": 0.4588,
"highlighted_in": "main_text"
},
{
"highlight": "Is <em>CVS</em> <em>Health</em> <em>Corporation</em> (CVS) the Best Health Insurance Stock to Buy Now?",
"sentiment": 0.6369,
"highlighted_in": "title"
}
]
},
{
"symbol": "0QZZ.L",
"name": "BlackRock, Inc.",
"exchange": null,
"exchange_long": null,
"country": "gb",
"type": "equity",
"industry": "N/A",
"match_score": 10.797423,
"sentiment_score": 0.6369,
"highlights": [
{
"highlight": "On another front, <em>BlackRock</em>, <em>Inc</em>. projects that the healthcare sector will have the highest 12-month forward earnings growth across all sectors on a year-on-year basis, with sales growth trailing only the consumer discretionary and information technology sectors.",
"sentiment": 0.6369,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "CVSH34.SA",
"name": "CVS Health Corporation",
"exchange": null,
"exchange_long": null,
"country": "br",
"type": "equity",
"industry": "Healthcare",
"match_score": 122.80061,
"sentiment_score": 0.3522,
"highlights": [
{
"highlight": "In this article, we are going to take a look at where <em>CVS</em> <em>Health</em> <em>Corporation</em> (NYSE:CVS) stands against the other health insurance stocks.\n\nThe Healthcare Market: What does the future hold?\n\n2023 posed significant challenges for the healthcare sector as investors adjusted their portfolios to adapt to a higher interest rate environment.",
"sentiment": 0.6249,
"highlighted_in": "main_text"
},
{
"highlight": "<em>CVS</em> <em>Health</em> <em>Corporation</em> (NYSE:CVS)\n\nNumber of Hedge Fund Holders: 54\n\n<em>CVS</em> <em>Health</em> <em>Corporation</em> (NYSE:CVS) is a U.S.-based healthcare enterprise that manages an extensive network of retail pharmacies and clinics across the country.",
"sentiment": 0.0772,
"highlighted_in": "main_text"
},
{
"highlight": "In early May, Argus revised its stock price target for <em>CVS</em> <em>Health</em> <em>Corporation</em> (NYSE:CVS), lowering it to $80 from the previous $100 while maintaining a Buy rating. This adjustment followed CVS Health’s first-quarter earnings for 2024, which fell short of market expectations and led the company to revise its guidance downward.",
"sentiment": -0.25,
"highlighted_in": "main_text"
},
{
"highlight": "Additionally, on May 23, <em>CVS</em> <em>Health</em> <em>Corporation</em> (NYSE:CVS) saw its shares decline by as much as 3% following an unconfirmed report that the company was seeking a private equity (PE) partnership to expand its Oak Street Health platform.",
"sentiment": 0.4588,
"highlighted_in": "main_text"
},
{
"highlight": "According to the report, <em>CVS</em> <em>Health</em> <em>Corporation</em> (NYSE:CVS) may pursue a partnership similar to Humana’s with Welsh Carson, where CVS would initially take a minority interest in new clinics with an option to purchase once they are established.",
"sentiment": 0.4588,
"highlighted_in": "main_text"
},
{
"highlight": "Ariel Global Fund stated the following regarding <em>CVS</em> <em>Health</em> <em>Corporation</em> (NYSE:CVS) in its first quarter 2024 investor letter:\n\n“We bought American healthcare company, <em>CVS</em> <em>Health</em> <em>Corporation</em> (NYSE:CVS), following recent concerns related to potential new laws affecting Pharmacy Benefit Managers (PBMs)—intermediaries that negotiate drug prices between",
"sentiment": 0.4588,
"highlighted_in": "main_text"
},
{
"highlight": "Is <em>CVS</em> <em>Health</em> <em>Corporation</em> (CVS) the Best Health Insurance Stock to Buy Now?",
"sentiment": 0.6369,
"highlighted_in": "title"
}
]
},
{
"symbol": "CVS.SN",
"name": "CVS Health Corporation",
"exchange": null,
"exchange_long": null,
"country": "cl",
"type": "equity",
"industry": "Healthcare",
"match_score": 122.7968,
"sentiment_score": 0.3522,
"highlights": [
{
"highlight": "In this article, we are going to take a look at where <em>CVS</em> <em>Health</em> <em>Corporation</em> (NYSE:CVS) stands against the other health insurance stocks.\n\nThe Healthcare Market: What does the future hold?\n\n2023 posed significant challenges for the healthcare sector as investors adjusted their portfolios to adapt to a higher interest rate environment.",
"sentiment": 0.6249,
"highlighted_in": "main_text"
},
{
"highlight": "<em>CVS</em> <em>Health</em> <em>Corporation</em> (NYSE:CVS)\n\nNumber of Hedge Fund Holders: 54\n\n<em>CVS</em> <em>Health</em> <em>Corporation</em> (NYSE:CVS) is a U.S.-based healthcare enterprise that manages an extensive network of retail pharmacies and clinics across the country.",
"sentiment": 0.0772,
"highlighted_in": "main_text"
},
{
"highlight": "In early May, Argus revised its stock price target for <em>CVS</em> <em>Health</em> <em>Corporation</em> (NYSE:CVS), lowering it to $80 from the previous $100 while maintaining a Buy rating. This adjustment followed CVS Health’s first-quarter earnings for 2024, which fell short of market expectations and led the company to revise its guidance downward.",
"sentiment": -0.25,
"highlighted_in": "main_text"
},
{
"highlight": "Additionally, on May 23, <em>CVS</em> <em>Health</em> <em>Corporation</em> (NYSE:CVS) saw its shares decline by as much as 3% following an unconfirmed report that the company was seeking a private equity (PE) partnership to expand its Oak Street Health platform.",
"sentiment": 0.4588,
"highlighted_in": "main_text"
},
{
"highlight": "According to the report, <em>CVS</em> <em>Health</em> <em>Corporation</em> (NYSE:CVS) may pursue a partnership similar to Humana’s with Welsh Carson, where CVS would initially take a minority interest in new clinics with an option to purchase once they are established.",
"sentiment": 0.4588,
"highlighted_in": "main_text"
},
{
"highlight": "Ariel Global Fund stated the following regarding <em>CVS</em> <em>Health</em> <em>Corporation</em> (NYSE:CVS) in its first quarter 2024 investor letter:\n\n“We bought American healthcare company, <em>CVS</em> <em>Health</em> <em>Corporation</em> (NYSE:CVS), following recent concerns related to potential new laws affecting Pharmacy Benefit Managers (PBMs)—intermediaries that negotiate drug prices between",
"sentiment": 0.4588,
"highlighted_in": "main_text"
},
{
"highlight": "Is <em>CVS</em> <em>Health</em> <em>Corporation</em> (CVS) the Best Health Insurance Stock to Buy Now?",
"sentiment": 0.6369,
"highlighted_in": "title"
}
]
},
{
"symbol": "CVSCL.SN",
"name": "CVS Health Corporation",
"exchange": null,
"exchange_long": null,
"country": "cl",
"type": "equity",
"industry": "N/A",
"match_score": 122.7968,
"sentiment_score": 0.3522,
"highlights": [
{
"highlight": "In this article, we are going to take a look at where <em>CVS</em> <em>Health</em> <em>Corporation</em> (NYSE:CVS) stands against the other health insurance stocks.\n\nThe Healthcare Market: What does the future hold?\n\n2023 posed significant challenges for the healthcare sector as investors adjusted their portfolios to adapt to a higher interest rate environment.",
"sentiment": 0.6249,
"highlighted_in": "main_text"
},
{
"highlight": "<em>CVS</em> <em>Health</em> <em>Corporation</em> (NYSE:CVS)\n\nNumber of Hedge Fund Holders: 54\n\n<em>CVS</em> <em>Health</em> <em>Corporation</em> (NYSE:CVS) is a U.S.-based healthcare enterprise that manages an extensive network of retail pharmacies and clinics across the country.",
"sentiment": 0.0772,
"highlighted_in": "main_text"
},
{
"highlight": "In early May, Argus revised its stock price target for <em>CVS</em> <em>Health</em> <em>Corporation</em> (NYSE:CVS), lowering it to $80 from the previous $100 while maintaining a Buy rating. This adjustment followed CVS Health’s first-quarter earnings for 2024, which fell short of market expectations and led the company to revise its guidance downward.",
"sentiment": -0.25,
"highlighted_in": "main_text"
},
{
"highlight": "Additionally, on May 23, <em>CVS</em> <em>Health</em> <em>Corporation</em> (NYSE:CVS) saw its shares decline by as much as 3% following an unconfirmed report that the company was seeking a private equity (PE) partnership to expand its Oak Street Health platform.",
"sentiment": 0.4588,
"highlighted_in": "main_text"
},
{
"highlight": "According to the report, <em>CVS</em> <em>Health</em> <em>Corporation</em> (NYSE:CVS) may pursue a partnership similar to Humana’s with Welsh Carson, where CVS would initially take a minority interest in new clinics with an option to purchase once they are established.",
"sentiment": 0.4588,
"highlighted_in": "main_text"
},
{
"highlight": "Ariel Global Fund stated the following regarding <em>CVS</em> <em>Health</em> <em>Corporation</em> (NYSE:CVS) in its first quarter 2024 investor letter:\n\n“We bought American healthcare company, <em>CVS</em> <em>Health</em> <em>Corporation</em> (NYSE:CVS), following recent concerns related to potential new laws affecting Pharmacy Benefit Managers (PBMs)—intermediaries that negotiate drug prices between",
"sentiment": 0.4588,
"highlighted_in": "main_text"
},
{
"highlight": "Is <em>CVS</em> <em>Health</em> <em>Corporation</em> (CVS) the Best Health Insurance Stock to Buy Now?",
"sentiment": 0.6369,
"highlighted_in": "title"
}
]
},
{
"symbol": "CVS.DE",
"name": "CVS Health Corporation",
"exchange": null,
"exchange_long": null,
"country": "de",
"type": "equity",
"industry": "Healthcare",
"match_score": 122.79436,
"sentiment_score": 0.3522,
"highlights": [
{
"highlight": "In this article, we are going to take a look at where <em>CVS</em> <em>Health</em> <em>Corporation</em> (NYSE:CVS) stands against the other health insurance stocks.\n\nThe Healthcare Market: What does the future hold?\n\n2023 posed significant challenges for the healthcare sector as investors adjusted their portfolios to adapt to a higher interest rate environment.",
"sentiment": 0.6249,
"highlighted_in": "main_text"
},
{
"highlight": "<em>CVS</em> <em>Health</em> <em>Corporation</em> (NYSE:CVS)\n\nNumber of Hedge Fund Holders: 54\n\n<em>CVS</em> <em>Health</em> <em>Corporation</em> (NYSE:CVS) is a U.S.-based healthcare enterprise that manages an extensive network of retail pharmacies and clinics across the country.",
"sentiment": 0.0772,
"highlighted_in": "main_text"
},
{
"highlight": "In early May, Argus revised its stock price target for <em>CVS</em> <em>Health</em> <em>Corporation</em> (NYSE:CVS), lowering it to $80 from the previous $100 while maintaining a Buy rating. This adjustment followed CVS Health’s first-quarter earnings for 2024, which fell short of market expectations and led the company to revise its guidance downward.",
"sentiment": -0.25,
"highlighted_in": "main_text"
},
{
"highlight": "Additionally, on May 23, <em>CVS</em> <em>Health</em> <em>Corporation</em> (NYSE:CVS) saw its shares decline by as much as 3% following an unconfirmed report that the company was seeking a private equity (PE) partnership to expand its Oak Street Health platform.",
"sentiment": 0.4588,
"highlighted_in": "main_text"
},
{
"highlight": "According to the report, <em>CVS</em> <em>Health</em> <em>Corporation</em> (NYSE:CVS) may pursue a partnership similar to Humana’s with Welsh Carson, where CVS would initially take a minority interest in new clinics with an option to purchase once they are established.",
"sentiment": 0.4588,
"highlighted_in": "main_text"
},
{
"highlight": "Ariel Global Fund stated the following regarding <em>CVS</em> <em>Health</em> <em>Corporation</em> (NYSE:CVS) in its first quarter 2024 investor letter:\n\n“We bought American healthcare company, <em>CVS</em> <em>Health</em> <em>Corporation</em> (NYSE:CVS), following recent concerns related to potential new laws affecting Pharmacy Benefit Managers (PBMs)—intermediaries that negotiate drug prices between",
"sentiment": 0.4588,
"highlighted_in": "main_text"
},
{
"highlight": "Is <em>CVS</em> <em>Health</em> <em>Corporation</em> (CVS) the Best Health Insurance Stock to Buy Now?",
"sentiment": 0.6369,
"highlighted_in": "title"
}
]
},
{
"symbol": "BLQA.DE",
"name": "BlackRock, Inc.",
"exchange": null,
"exchange_long": null,
"country": "de",
"type": "equity",
"industry": "Financial Services",
"match_score": 10.796847,
"sentiment_score": 0.6369,
"highlights": [
{
"highlight": "On another front, <em>BlackRock</em>, <em>Inc</em>. projects that the healthcare sector will have the highest 12-month forward earnings growth across all sectors on a year-on-year basis, with sales growth trailing only the consumer discretionary and information technology sectors.",
"sentiment": 0.6369,
"highlighted_in": "main_text"
}
]
}
]
},
{
"uuid": "f55101b2-906e-402e-b178-7cb8b8ead89b",
"title": "Chubb Limited (CB): The Best Health Insurance Stock According to Hedge Funds?",
"description": "We recently compiled a list of the 10 Best Health Insurance Stocks to Buy.",
"keywords": "",
"snippet": "We recently compiled a list of the 10 Best Health Insurance Stocks to Buy. In this article, we are going to take a look at where Chubb Limited (NYSE:CB) stands ...",
"url": "https://www.insidermonkey.com/blog/chubb-limited-cb-the-best-health-insurance-stock-according-to-hedge-funds-1326711/",
"image_url": "https://d2gr5kl7dt2z3t.cloudfront.net/blog/wp-content/uploads/2023/09/23144928/CB-insidermonkey-1695494965911.jpg",
"language": "en",
"published_at": "2024-07-27T02:05:59.000000Z",
"source": "insidermonkey.com",
"relevance_score": null,
"entities": [
{
"symbol": "BLK.MX",
"name": "BlackRock, Inc.",
"exchange": null,
"exchange_long": null,
"country": "mx",
"type": "equity",
"industry": "Financial Services",
"match_score": 11.531286,
"sentiment_score": 0.6369,
"highlights": [
{
"highlight": "On another front, <em>BlackRock</em>, <em>Inc</em>. projects that the healthcare sector will have the highest 12-month forward earnings growth across all sectors on a year-on-year basis, with sales growth trailing only the consumer discretionary and information technology sectors.",
"sentiment": 0.6369,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "CBN.MX",
"name": "Chubb Limited",
"exchange": null,
"exchange_long": null,
"country": "mx",
"type": "equity",
"industry": "N/A",
"match_score": 86.749344,
"sentiment_score": 0.5513,
"highlights": [
{
"highlight": "In this article, we are going to take a look at where <em>Chubb</em> <em>Limited</em> (NYSE:CB) stands against the other health insurance stocks.\n\nThe Healthcare Market: What does the future hold?\n\n2023 posed significant challenges for the healthcare sector as investors adjusted their portfolios to adapt to a higher interest rate environment.",
"sentiment": 0.6249,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Chubb</em> <em>Limited</em> (NYSE:CB)\n\nNumber of Hedge Fund Holders: 53\n\n<em>Chubb</em> <em>Limited</em> (NYSE:CB) is a global insurance corporation offering a wide range of insurance and reinsurance products to individuals, businesses, and other entities worldwide.",
"sentiment": 0.0772,
"highlighted_in": "main_text"
},
{
"highlight": "These improvements were partially influenced by two one-time items: a $55 million deferred tax benefit related to Bermuda tax law and a $30 million contribution to the <em>Chubb</em> Charitable Foundation.\n\nAdditionally, Warren Buffett’s Berkshire Hathaway revealed a significant investment in <em>Chubb</em> <em>Limited</em> (NYSE:CB).",
"sentiment": 0.8316,
"highlighted_in": "main_text"
},
{
"highlight": "Following the news of Berkshire’s investment, shares of <em>Chubb</em> <em>Limited</em> (NYSE:CB) jumped nearly 7% in extended trading. The stock has gained approximately 16.5% year to date.\n\nOut of the 919 hedge funds tracked by Insider Monkey, 53 reported owning stock in <em>Chubb</em> <em>Limited</em> (NYSE:CB) as of Q1 2024.",
"sentiment": 0.5859,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Chubb</em> <em>Limited</em> (CB): The Best Health Insurance Stock According to Hedge Funds?",
"sentiment": 0.6369,
"highlighted_in": "title"
}
]
},
{
"symbol": "BLK",
"name": "BlackRock, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Financial Services",
"match_score": 11.531115,
"sentiment_score": 0.6369,
"highlights": [
{
"highlight": "On another front, <em>BlackRock</em>, <em>Inc</em>. projects that the healthcare sector will have the highest 12-month forward earnings growth across all sectors on a year-on-year basis, with sales growth trailing only the consumer discretionary and information technology sectors.",
"sentiment": 0.6369,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "CB",
"name": "Chubb Limited",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Financial Services",
"match_score": 105.30945,
"sentiment_score": 0.5513,
"highlights": [
{
"highlight": "In this article, we are going to take a look at where <em>Chubb</em> <em>Limited</em> (<em>NYSE:CB</em>) stands against the other health insurance stocks.\n\nThe Healthcare Market: What does the future hold?\n\n2023 posed significant challenges for the healthcare sector as investors adjusted their portfolios to adapt to a higher interest rate environment.",
"sentiment": 0.6249,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Chubb</em> <em>Limited</em> (<em>NYSE:CB</em>)\n\nNumber of Hedge Fund Holders: 53\n\n<em>Chubb</em> <em>Limited</em> (<em>NYSE:CB</em>) is a global insurance corporation offering a wide range of insurance and reinsurance products to individuals, businesses, and other entities worldwide.",
"sentiment": 0.0772,
"highlighted_in": "main_text"
},
{
"highlight": "These improvements were partially influenced by two one-time items: a $55 million deferred tax benefit related to Bermuda tax law and a $30 million contribution to the <em>Chubb</em> Charitable Foundation.\n\nAdditionally, Warren Buffett’s Berkshire Hathaway revealed a significant investment in <em>Chubb</em> <em>Limited</em> (<em>NYSE:CB</em>).",
"sentiment": 0.8316,
"highlighted_in": "main_text"
},
{
"highlight": "Following the news of Berkshire’s investment, shares of <em>Chubb</em> <em>Limited</em> (<em>NYSE:CB</em>) jumped nearly 7% in extended trading. The stock has gained approximately 16.5% year to date.\n\nOut of the 919 hedge funds tracked by Insider Monkey, 53 reported owning stock in <em>Chubb</em> <em>Limited</em> (<em>NYSE:CB</em>) as of Q1 2024.",
"sentiment": 0.5859,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Chubb</em> <em>Limited</em> (CB): The Best Health Insurance Stock According to Hedge Funds?",
"sentiment": 0.6369,
"highlighted_in": "title"
}
]
},
{
"symbol": "0QZZ.L",
"name": "BlackRock, Inc.",
"exchange": null,
"exchange_long": null,
"country": "gb",
"type": "equity",
"industry": "N/A",
"match_score": 11.530846,
"sentiment_score": 0.6369,
"highlights": [
{
"highlight": "On another front, <em>BlackRock</em>, <em>Inc</em>. projects that the healthcare sector will have the highest 12-month forward earnings growth across all sectors on a year-on-year basis, with sales growth trailing only the consumer discretionary and information technology sectors.",
"sentiment": 0.6369,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "C1BL34.SA",
"name": "Chubb Limited",
"exchange": null,
"exchange_long": null,
"country": "br",
"type": "equity",
"industry": "Financial Services",
"match_score": 86.75801,
"sentiment_score": 0.5513,
"highlights": [
{
"highlight": "In this article, we are going to take a look at where <em>Chubb</em> <em>Limited</em> (NYSE:CB) stands against the other health insurance stocks.\n\nThe Healthcare Market: What does the future hold?\n\n2023 posed significant challenges for the healthcare sector as investors adjusted their portfolios to adapt to a higher interest rate environment.",
"sentiment": 0.6249,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Chubb</em> <em>Limited</em> (NYSE:CB)\n\nNumber of Hedge Fund Holders: 53\n\n<em>Chubb</em> <em>Limited</em> (NYSE:CB) is a global insurance corporation offering a wide range of insurance and reinsurance products to individuals, businesses, and other entities worldwide.",
"sentiment": 0.0772,
"highlighted_in": "main_text"
},
{
"highlight": "These improvements were partially influenced by two one-time items: a $55 million deferred tax benefit related to Bermuda tax law and a $30 million contribution to the <em>Chubb</em> Charitable Foundation.\n\nAdditionally, Warren Buffett’s Berkshire Hathaway revealed a significant investment in <em>Chubb</em> <em>Limited</em> (NYSE:CB).",
"sentiment": 0.8316,
"highlighted_in": "main_text"
},
{
"highlight": "Following the news of Berkshire’s investment, shares of <em>Chubb</em> <em>Limited</em> (NYSE:CB) jumped nearly 7% in extended trading. The stock has gained approximately 16.5% year to date.\n\nOut of the 919 hedge funds tracked by Insider Monkey, 53 reported owning stock in <em>Chubb</em> <em>Limited</em> (NYSE:CB) as of Q1 2024.",
"sentiment": 0.5859,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Chubb</em> <em>Limited</em> (CB): The Best Health Insurance Stock According to Hedge Funds?",
"sentiment": 0.6369,
"highlighted_in": "title"
}
]
},
{
"symbol": "BRKB.BA",
"name": "BERKSHIRE HATHAWAY",
"exchange": null,
"exchange_long": null,
"country": "ar",
"type": "equity",
"industry": "N/A",
"match_score": 19.272717,
"sentiment_score": 0.4588,
"highlights": [
{
"highlight": "Additionally, Warren Buffett’s <em>Berkshire</em> <em>Hathaway</em> revealed a significant investment in Chubb Limited (NYSE:CB). The conglomerate purchased nearly 26 million shares of the Zurich-based insurer, a stake worth $6.7 billion, making it Berkshire’s ninth-largest holding as of the end of March.",
"sentiment": 0.4588,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "BRKBD.BA",
"name": "BERKSHIRE HATHAWAY",
"exchange": null,
"exchange_long": null,
"country": "ar",
"type": "equity",
"industry": "N/A",
"match_score": 19.272717,
"sentiment_score": 0.4588,
"highlights": [
{
"highlight": "Additionally, Warren Buffett’s <em>Berkshire</em> <em>Hathaway</em> revealed a significant investment in Chubb Limited (NYSE:CB). The conglomerate purchased nearly 26 million shares of the Zurich-based insurer, a stake worth $6.7 billion, making it Berkshire’s ninth-largest holding as of the end of March.",
"sentiment": 0.4588,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "BRKBB.BA",
"name": "BERKSHIRE HATHAWAY",
"exchange": null,
"exchange_long": null,
"country": "ar",
"type": "equity",
"industry": "N/A",
"match_score": 19.272717,
"sentiment_score": 0.4588,
"highlights": [
{
"highlight": "Additionally, Warren Buffett’s <em>Berkshire</em> <em>Hathaway</em> revealed a significant investment in Chubb Limited (NYSE:CB). The conglomerate purchased nearly 26 million shares of the Zurich-based insurer, a stake worth $6.7 billion, making it Berkshire’s ninth-largest holding as of the end of March.",
"sentiment": 0.4588,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "BLQA.DE",
"name": "BlackRock, Inc.",
"exchange": null,
"exchange_long": null,
"country": "de",
"type": "equity",
"industry": "Financial Services",
"match_score": 11.530273,
"sentiment_score": 0.6369,
"highlights": [
{
"highlight": "On another front, <em>BlackRock</em>, <em>Inc</em>. projects that the healthcare sector will have the highest 12-month forward earnings growth across all sectors on a year-on-year basis, with sales growth trailing only the consumer discretionary and information technology sectors.",
"sentiment": 0.6369,
"highlighted_in": "main_text"
}
]
}
]
}
]
},
{
"uuid": "04c505e1-d040-465d-9d5b-b101d391be3c",
"title": "Why Are Hedge Funds Bullish on HCA Healthcare, Inc. (HCA)?",
"description": "We recently compiled a list of the 10 Best Health Insurance Stocks to Buy. In this article, we are going to take a look at where HCA Healthcare, Inc.",
"keywords": "",
"snippet": "We recently compiled a list of the 10 Best Health Insurance Stocks to Buy. In this article, we are going to take a look at where HCA Healthcare, Inc. (NYSE:HCA)...",
"url": "https://www.insidermonkey.com/blog/why-are-hedge-funds-bullish-on-hca-healthcare-inc-hca-1326739/",
"image_url": "https://d2gr5kl7dt2z3t.cloudfront.net/blog/wp-content/uploads/2023/09/21041524/HCA-insidermonkey-1695284121488.jpg",
"language": "en",
"published_at": "2024-07-27T02:31:06.000000Z",
"source": "insidermonkey.com",
"relevance_score": null,
"entities": [
{
"symbol": "BLK.MX",
"name": "BlackRock, Inc.",
"exchange": null,
"exchange_long": null,
"country": "mx",
"type": "equity",
"industry": "Financial Services",
"match_score": 10.797828,
"sentiment_score": 0.6369,
"highlights": [
{
"highlight": "On another front, <em>BlackRock</em>, <em>Inc</em>. projects that the healthcare sector will have the highest 12-month forward earnings growth across all sectors on a year-on-year basis, with sales growth trailing only the consumer discretionary and information technology sectors.",
"sentiment": 0.6369,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "HCA.MX",
"name": "HCA Healthcare, Inc.",
"exchange": null,
"exchange_long": null,
"country": "mx",
"type": "equity",
"industry": "Healthcare",
"match_score": 135.2063,
"sentiment_score": 0.488278,
"highlights": [
{
"highlight": "In this article, we are going to take a look at where <em>HCA</em> <em>Healthcare</em>, <em>Inc</em>. (NYSE:HCA) stands against the other health insurance stocks.\n\nThe Healthcare Market: What does the future hold?\n\n2023 posed significant challenges for the healthcare sector as investors adjusted their portfolios to adapt to a higher interest rate environment.",
"sentiment": 0.6249,
"highlighted_in": "main_text"
},
{
"highlight": "<em>HCA</em> <em>Healthcare</em>, <em>Inc</em>. (NYSE:HCA)\n\nNumber of Hedge Fund Holders: 72\n\nFounded in 1968, <em>HCA</em> <em>Healthcare</em>, <em>Inc</em>. (NYSE:HCA) is a leading healthcare provider known for its extensive network, owning and operating 182 hospitals and approximately 2,300 ambulatory care sites.",
"sentiment": -0.1027,
"highlighted_in": "main_text"
},
{
"highlight": "<em>HCA</em> <em>Healthcare</em>, <em>Inc</em>. (NYSE:HCA) had a notable first quarter in 2024, showcasing strong financial results and significant growth in inpatient admissions, surgeries, and emergency room visits. Although there was a decline in outpatient surgery revenue, the company’s adjusted earnings per share increased to $5.36, reflecting nearly a 9% rise.",
"sentiment": 0.8126,
"highlighted_in": "main_text"
},
{
"highlight": "This revision, which considers the first-quarter performance and a perceived softening in the trend environment, led TD Cowen to adjust its projections for <em>HCA</em> <em>Healthcare</em>, <em>Inc</em>. (NYSE:HCA)’s EBITDA in 2024 and 2025, as well as its 2025 enterprise value to EBITDA minus net corporate income target multiple.",
"sentiment": 0.5423,
"highlighted_in": "main_text"
},
{
"highlight": "As of Q1 2024, 72 hedge funds held positions in <em>HCA</em> <em>Healthcare</em>, <em>Inc</em>. (NYSE:HCA) The fund with the largest stake was First Eagle Investment Management, holding 4.5 million shares, which comprised 3.41% of their portfolio.\n\nDiamond Hill Large Cap Strategy stated the following regarding <em>HCA</em> <em>Healthcare</em>, <em>Inc</em>.",
"sentiment": 0.5574,
"highlighted_in": "main_text"
},
{
"highlight": "(NYSE:HCA) in its first quarter 2024 investor letter:\n\n“Among our top individual contributors in Q1 were American International Group (AIG) and <em>HCA</em> <em>Healthcare</em>, <em>Inc</em>. (NYSE:HCA).",
"sentiment": 0.2023,
"highlighted_in": "main_text"
},
{
"highlight": "Health care facilities operator <em>HCA</em> <em>Healthcare</em> benefited from a strong demand environment for hospitals in Q4, which is expected to continue into 2024 as nursing labor costs normalize and companies are able to improve margins tied to above-average physician costs.",
"sentiment": 0.836,
"highlighted_in": "main_text"
},
{
"highlight": "As a best-in-class operator with unique assets in favorable geographies, we believe the outlook for <em>HCA</em> <em>Healthcare</em> from here is favorable.”\n\nOverall HCA ranks 5th on our list of the best health insurance stocks to buy. You can visit 10 Best Health Insurance Stocks to Buy to see the other health insurance stocks that are on hedge funds’ radar.",
"sentiment": 0.9217,
"highlighted_in": "main_text"
},
{
"highlight": "Why Are Hedge Funds Bullish on <em>HCA</em> <em>Healthcare</em>, <em>Inc</em>. (HCA)?",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
],
"similar": []
},
{
"uuid": "8f09f8aa-be0c-417f-ae7e-866a4f068f07",
"title": "The Week Ahead: FOMC meeting in focus, US Democratic presidential candidate could be announced",
"description": "The main focus this week will be the US Federal Open Market Committee (FOMC) meeting on July 30 and 31.",
"keywords": "",
"snippet": "This article first appeared in The Edge Malaysia Weekly on July 29, 2024 - August 4, 2024\n\nThe main focus this week will be the US Federal Open Market Committee...",
"url": "https://theedgemalaysia.com/node/720634",
"image_url": "https://assets.theedgemarkets.com/FS_WA_TEM1534_The-Week-Ahead_theedgemalaysia.jpg",
"language": "en",
"published_at": "2024-07-27T02:00:00.000000Z",
"source": "theedgemarkets.com",
"relevance_score": null,
"entities": [
{
"symbol": "AMZN.MX",
"name": "Amazon.com, Inc.",
"exchange": null,
"exchange_long": null,
"country": "mx",
"type": "equity",
"industry": "Consumer Cyclical",
"match_score": 14.473173,
"sentiment_score": 0.25,
"highlights": [
{
"highlight": "In the US corporate earnings season, big technology stocks Apple Inc, <em>Amazon.com</em> <em>Inc</em>, PayPal Holdings Inc, Meta Platforms Inc, Microsoft Corp, Intel Corp and Advanced Micro Devices Inc are set to announce their latest quarterly earnings this week.",
"sentiment": 0.25,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "AAPL.MX",
"name": "Apple Inc.",
"exchange": null,
"exchange_long": null,
"country": "mx",
"type": "equity",
"industry": "Technology",
"match_score": 10.176394,
"sentiment_score": 0.25,
"highlights": [
{
"highlight": "In the US corporate earnings season, big technology stocks <em>Apple</em> <em>Inc</em>, Amazon.com Inc, PayPal Holdings Inc, Meta Platforms Inc, Microsoft Corp, Intel Corp and Advanced Micro Devices Inc are set to announce their latest quarterly earnings this week.",
"sentiment": 0.25,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "AMD.MX",
"name": "Advanced Micro Devices, Inc.",
"exchange": null,
"exchange_long": null,
"country": "mx",
"type": "equity",
"industry": "Technology",
"match_score": 27.069485,
"sentiment_score": 0,
"highlights": [
{
"highlight": "In the US corporate earnings season, big technology stocks Apple Inc, Amazon.com Inc, PayPal Holdings Inc, Meta Platforms Inc, Microsoft Corp, Intel Corp and <em>Advanced</em> <em>Micro</em> <em>Devices</em> <em>Inc</em> are set to announce their latest quarterly earnings this week.",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "PYPL.MX",
"name": "PayPal Holdings, Inc.",
"exchange": null,
"exchange_long": null,
"country": "mx",
"type": "equity",
"industry": "Financial Services",
"match_score": 21.020763,
"sentiment_score": 0.25,
"highlights": [
{
"highlight": "In the US corporate earnings season, big technology stocks Apple Inc, Amazon.com Inc, <em>PayPal</em> <em>Holdings</em> <em>Inc</em>, Meta Platforms Inc, Microsoft Corp, Intel Corp and Advanced Micro Devices Inc are set to announce their latest quarterly earnings this week.",
"sentiment": 0.25,
"highlighted_in": "main_text"
}
]
}
],
"similar": []
},
{
"uuid": "00f2c6c5-dcdd-4453-93e2-ce43150118cb",
"title": "VICOR ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Vicor Corporation and Encourages Investors to Contact the Firm",
"description": "NEW YORK, July 26, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class...",
"keywords": "Bragar Eagel & Squire, Vicor Corporation, VICR, securities, class action, stockholder rights, legal, lawyer, litigate, lawsuit, complaint, share, stock, investor, invest, Class Action",
"snippet": "NEW YORK, July 26, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action laws...",
"url": "https://www.globenewswire.com/news-release/2024/07/27/2919927/0/en/VICOR-ALERT-Bragar-Eagel-Squire-P-C-Announces-that-a-Class-Action-Lawsuit-Has-Been-Filed-Against-Vicor-Corporation-and-Encourages-Investors-to-Contact-the-Firm.html",
"image_url": "https://ml.globenewswire.com/Resource/Download/29481954-f2ff-4756-b5a9-d982a6497bd0",
"language": "en",
"published_at": "2024-07-27T02:00:00.000000Z",
"source": "globenewswire.com",
"relevance_score": null,
"entities": [
{
"symbol": "NVDA.MX",
"name": "NVIDIA Corporation",
"exchange": null,
"exchange_long": null,
"country": "mx",
"type": "equity",
"industry": "Technology",
"match_score": 17.952593,
"sentiment_score": 0.3612,
"highlights": [
{
"highlight": "According to the complaint, during the class period, Defendants created the false and/or materially misleading impression that Vicor had secured a significant deal for its H100 product that, according to analysts, was <em>Nvidia</em> <em>Corporation</em>.",
"sentiment": 0.3612,
"highlighted_in": "main_text"
}
]
}
],
"similar": [
{
"uuid": "2f27f2eb-3680-4488-969b-9b305a9a78e3",
"title": "ROSEN, LEADING INVESTOR COUNSEL, Encourages CAE Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – CAE",
"description": "NEW YORK, July 26, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on...",
"keywords": "The Rosen Law Firm PA, NYSE: CAE, CAE, Class Action",
"snippet": "NEW YORK, July 26, 2024 (GLOBE NEWSWIRE) --\n\nWHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on all purch...",
"url": "https://www.globenewswire.com/news-release/2024/07/26/2919903/673/en/ROSEN-LEADING-INVESTOR-COUNSEL-Encourages-CAE-Inc-Investors-to-Secure-Counsel-Before-Important-Deadline-in-Securities-Class-Action-CAE.html",
"image_url": "https://ml.globenewswire.com/Resource/Download/745335af-3a3a-4fb5-84c0-fdedc9adf092",
"language": "en",
"published_at": "2024-07-26T22:15:00.000000Z",
"source": "globenewswire.com",
"relevance_score": null,
"entities": [
{
"symbol": "CAE.TO",
"name": "CAE Inc.",
"exchange": null,
"exchange_long": null,
"country": "ca",
"type": "equity",
"industry": "Industrials",
"match_score": 61.197388,
"sentiment_score": 0.531425,
"highlights": [
{
"highlight": "NEW YORK, July 26, 2024 (GLOBE NEWSWIRE) --\n\nWHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on all purchasers and acquirers of stock on an exchange in the United States of <em>CAE</em> <em>Inc</em>. (NYSE: <em>CAE</em>) between February 11, 2022 and May 21, 2024, both dates inclusive (the “Class Period”).",
"sentiment": 0.2263,
"highlighted_in": "main_text"
},
{
"highlight": "SO WHAT: If you purchased <em>CAE</em> securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.\n\nWHAT TO DO NEXT: To join the <em>CAE</em> class action, go to https://rosenlegal.com/submit-form/?",
"sentiment": 0.6705,
"highlighted_in": "main_text"
},
{
"highlight": "In truth, certain of CAE’s pre-COVID fixed-price Defense contracts had experienced such significant cost overruns that <em>CAE</em> needed to take over $720 million in charges and profit adjustments and “re-baselin[e]” its entire Defense business. When the true details entered the market, the lawsuit claims that investors suffered damages.",
"sentiment": 0.4215,
"highlighted_in": "main_text"
},
{
"highlight": "ROSEN, LEADING INVESTOR COUNSEL, Encourages <em>CAE</em> <em>Inc</em>. Investors to Secure Counsel Before Important Deadline in Securities Class Action – <em>CAE</em>",
"sentiment": 0.8074,
"highlighted_in": "title"
}
]
},
{
"symbol": "CAE",
"name": "CAE Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Industrials",
"match_score": 46.71149,
"sentiment_score": 0.51685,
"highlights": [
{
"highlight": "NEW YORK, July 26, 2024 (GLOBE NEWSWIRE) --\n\nWHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on all purchasers and acquirers of stock on an exchange in the United States of <em>CAE</em> <em>Inc</em>. (<em>NYSE</em>: <em>CAE</em>) between February 11, 2022 and May 21, 2024, both dates inclusive (the “Class Period”).",
"sentiment": 0.2263,
"highlighted_in": "main_text"
},
{
"highlight": "ROSEN, LEADING INVESTOR COUNSEL, Encourages <em>CAE</em> <em>Inc</em>. Investors to Secure Counsel Before Important Deadline in Securities Class Action – CAE",
"sentiment": 0.8074,
"highlighted_in": "title"
}
]
},
{
"symbol": "CAEN.MX",
"name": "CAE Inc.",
"exchange": null,
"exchange_long": null,
"country": "mx",
"type": "equity",
"industry": "N/A",
"match_score": 61.197372,
"sentiment_score": 0.531425,
"highlights": [
{
"highlight": "NEW YORK, July 26, 2024 (GLOBE NEWSWIRE) --\n\nWHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on all purchasers and acquirers of stock on an exchange in the United States of <em>CAE</em> <em>Inc</em>. (NYSE: <em>CAE</em>) between February 11, 2022 and May 21, 2024, both dates inclusive (the “Class Period”).",
"sentiment": 0.2263,
"highlighted_in": "main_text"
},
{
"highlight": "SO WHAT: If you purchased <em>CAE</em> securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.\n\nWHAT TO DO NEXT: To join the <em>CAE</em> class action, go to https://rosenlegal.com/submit-form/?",
"sentiment": 0.6705,
"highlighted_in": "main_text"
},
{
"highlight": "In truth, certain of CAE’s pre-COVID fixed-price Defense contracts had experienced such significant cost overruns that <em>CAE</em> needed to take over $720 million in charges and profit adjustments and “re-baselin[e]” its entire Defense business. When the true details entered the market, the lawsuit claims that investors suffered damages.",
"sentiment": 0.4215,
"highlighted_in": "main_text"
},
{
"highlight": "ROSEN, LEADING INVESTOR COUNSEL, Encourages <em>CAE</em> <em>Inc</em>. Investors to Secure Counsel Before Important Deadline in Securities Class Action – <em>CAE</em>",
"sentiment": 0.8074,
"highlighted_in": "title"
}
]
}
]
},
{
"uuid": "74f6ec38-a9c2-4fc7-bf85-aa65c428f8b8",
"title": "ROSEN, LEADING INVESTOR COUNSEL, Encourages CVS Health Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – CVS",
"description": "NEW YORK, July 26, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on...",
"keywords": "The Rosen Law Firm PA, CVS Health Corporation, NYSE: CVS, Class Action",
"snippet": "NEW YORK, July 26, 2024 (GLOBE NEWSWIRE) --\n\nWHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of...",
"url": "https://www.globenewswire.com/news-release/2024/07/26/2919900/673/en/ROSEN-LEADING-INVESTOR-COUNSEL-Encourages-CVS-Health-Corporation-Investors-to-Secure-Counsel-Before-Important-Deadline-in-Securities-Class-Action-CVS.html",
"image_url": "https://ml.globenewswire.com/Resource/Download/745335af-3a3a-4fb5-84c0-fdedc9adf092",
"language": "en",
"published_at": "2024-07-26T21:29:00.000000Z",
"source": "globenewswire.com",
"relevance_score": null,
"entities": [
{
"symbol": "CVS.SN",
"name": "CVS Health Corporation",
"exchange": null,
"exchange_long": null,
"country": "cl",
"type": "equity",
"industry": "Healthcare",
"match_score": 94.139465,
"sentiment_score": 0.4423,
"highlights": [
{
"highlight": "NEW YORK, July 26, 2024 (GLOBE NEWSWIRE) --\n\nWHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of <em>CVS</em> <em>Health</em> <em>Corporation</em> (NYSE: CVS) between May 3, 2023 and April 30, 2024, both dates inclusive (the “Class Period”).",
"sentiment": 0.0772,
"highlighted_in": "main_text"
},
{
"highlight": "ROSEN, LEADING INVESTOR COUNSEL, Encourages <em>CVS</em> <em>Health</em> <em>Corporation</em> Investors to Secure Counsel Before Important Deadline in Securities Class Action – CVS",
"sentiment": 0.8074,
"highlighted_in": "title"
}
]
},
{
"symbol": "CVSCL.SN",
"name": "CVS Health Corporation",
"exchange": null,
"exchange_long": null,
"country": "cl",
"type": "equity",
"industry": "N/A",
"match_score": 94.1395,
"sentiment_score": 0.4423,
"highlights": [
{
"highlight": "NEW YORK, July 26, 2024 (GLOBE NEWSWIRE) --\n\nWHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of <em>CVS</em> <em>Health</em> <em>Corporation</em> (NYSE: CVS) between May 3, 2023 and April 30, 2024, both dates inclusive (the “Class Period”).",
"sentiment": 0.0772,
"highlighted_in": "main_text"
},
{
"highlight": "ROSEN, LEADING INVESTOR COUNSEL, Encourages <em>CVS</em> <em>Health</em> <em>Corporation</em> Investors to Secure Counsel Before Important Deadline in Securities Class Action – CVS",
"sentiment": 0.8074,
"highlighted_in": "title"
}
]
},
{
"symbol": "CVS",
"name": "CVS Health Corporation",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 108.3095,
"sentiment_score": 0.4423,
"highlights": [
{
"highlight": "NEW YORK, July 26, 2024 (GLOBE NEWSWIRE) --\n\nWHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of <em>CVS</em> <em>Health</em> <em>Corporation</em> (<em>NYSE</em>: <em>CVS</em>) between May 3, 2023 and April 30, 2024, both dates inclusive (the “Class Period”).",
"sentiment": 0.0772,
"highlighted_in": "main_text"
},
{
"highlight": "ROSEN, LEADING INVESTOR COUNSEL, Encourages <em>CVS</em> <em>Health</em> <em>Corporation</em> Investors to Secure Counsel Before Important Deadline in Securities Class Action – CVS",
"sentiment": 0.8074,
"highlighted_in": "title"
}
]
},
{
"symbol": "CVS.DE",
"name": "CVS Health Corporation",
"exchange": null,
"exchange_long": null,
"country": "de",
"type": "equity",
"industry": "Healthcare",
"match_score": 94.136475,
"sentiment_score": 0.4423,
"highlights": [
{
"highlight": "NEW YORK, July 26, 2024 (GLOBE NEWSWIRE) --\n\nWHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of <em>CVS</em> <em>Health</em> <em>Corporation</em> (NYSE: CVS) between May 3, 2023 and April 30, 2024, both dates inclusive (the “Class Period”).",
"sentiment": 0.0772,
"highlighted_in": "main_text"
},
{
"highlight": "ROSEN, LEADING INVESTOR COUNSEL, Encourages <em>CVS</em> <em>Health</em> <em>Corporation</em> Investors to Secure Counsel Before Important Deadline in Securities Class Action – CVS",
"sentiment": 0.8074,
"highlighted_in": "title"
}
]
},
{
"symbol": "CVS.MX",
"name": "CVS Health Corporation",
"exchange": null,
"exchange_long": null,
"country": "mx",
"type": "equity",
"industry": "Healthcare",
"match_score": 94.13387,
"sentiment_score": 0.4423,
"highlights": [
{
"highlight": "NEW YORK, July 26, 2024 (GLOBE NEWSWIRE) --\n\nWHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of <em>CVS</em> <em>Health</em> <em>Corporation</em> (NYSE: CVS) between May 3, 2023 and April 30, 2024, both dates inclusive (the “Class Period”).",
"sentiment": 0.0772,
"highlighted_in": "main_text"
},
{
"highlight": "ROSEN, LEADING INVESTOR COUNSEL, Encourages <em>CVS</em> <em>Health</em> <em>Corporation</em> Investors to Secure Counsel Before Important Deadline in Securities Class Action – CVS",
"sentiment": 0.8074,
"highlighted_in": "title"
}
]
},
{
"symbol": "0HRS.L",
"name": "CVS Health Corporation",
"exchange": null,
"exchange_long": null,
"country": "gb",
"type": "equity",
"industry": "N/A",
"match_score": 94.135506,
"sentiment_score": 0.4423,
"highlights": [
{
"highlight": "NEW YORK, July 26, 2024 (GLOBE NEWSWIRE) --\n\nWHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of <em>CVS</em> <em>Health</em> <em>Corporation</em> (NYSE: CVS) between May 3, 2023 and April 30, 2024, both dates inclusive (the “Class Period”).",
"sentiment": 0.0772,
"highlighted_in": "main_text"
},
{
"highlight": "ROSEN, LEADING INVESTOR COUNSEL, Encourages <em>CVS</em> <em>Health</em> <em>Corporation</em> Investors to Secure Counsel Before Important Deadline in Securities Class Action – CVS",
"sentiment": 0.8074,
"highlighted_in": "title"
}
]
},
{
"symbol": "CVSH34.SA",
"name": "CVS Health Corporation",
"exchange": null,
"exchange_long": null,
"country": "br",
"type": "equity",
"industry": "Healthcare",
"match_score": 94.13162,
"sentiment_score": 0.4423,
"highlights": [
{
"highlight": "NEW YORK, July 26, 2024 (GLOBE NEWSWIRE) --\n\nWHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of <em>CVS</em> <em>Health</em> <em>Corporation</em> (NYSE: CVS) between May 3, 2023 and April 30, 2024, both dates inclusive (the “Class Period”).",
"sentiment": 0.0772,
"highlighted_in": "main_text"
},
{
"highlight": "ROSEN, LEADING INVESTOR COUNSEL, Encourages <em>CVS</em> <em>Health</em> <em>Corporation</em> Investors to Secure Counsel Before Important Deadline in Securities Class Action – CVS",
"sentiment": 0.8074,
"highlighted_in": "title"
}
]
}
]
}
]
},
{
"uuid": "2a90c3eb-37c3-4e2d-93ac-c682c031cc78",
"title": "Американский банк State Street заплатит США $7,5 млн за нарушение антироссийских санкций",
"description": "Сделано это, чтобы избежать гражданского иска",
"keywords": "",
"snippet": "Нарушения банком были допущены в 2016-2020 годах, об этом пишут РИА Новости, ссылаясь на дан?...",
"url": "https://rb.ru/news/state-street/",
"image_url": "https://media.rbcdn.ru/media/news/mjcumdcumjaynf8wmdowmhn0yxrllxn0cmvlda.jpg",
"language": "ru",
"published_at": "2024-07-27T01:58:08.000000Z",
"source": "rb.ru",
"relevance_score": null,
"entities": [
{
"symbol": "STT.MX",
"name": "State Street Corporation",
"exchange": null,
"exchange_long": null,
"country": "mx",
"type": "equity",
"industry": "Financial Services",
"match_score": 53.5513,
"sentiment_score": null,
"highlights": [
{
"highlight": "«<em>State</em> <em>Street</em> согласился на досудебное урегулирование возможной гражданкой ответственности за 38 очевидных нарушений санкций офиса по контролю за иностранными активами минфина», — сказано в заявлении ведомства.",
"sentiment": null,
"highlighted_in": "main_text"
},
{
"highlight": "<em>State</em> <em>Street</em> <em>Corporation</em> — американская холдинговая компания, которая в настоящий момент ведет не только депозитарную, но и инвестиционную деятельность. Это второй старейший из ныне действующих банков США. Его штаб-квартира расположеноа в Бостоне (штат Массачусетс).",
"sentiment": null,
"highlighted_in": "main_text"
},
{
"highlight": "Американский банк <em>State</em> <em>Street</em> заплатит США $7,5 млн за нарушение антироссийских санкций",
"sentiment": null,
"highlighted_in": "title"
}
]
}
],
"similar": []
},
{
"uuid": "eb53d83d-e209-45f8-9b1d-e8d47349c66d",
"title": "The Most Respected Country in Asia in 2024",
"description": "Today's economic and political disruptions frequently position Asia at the forefront, as its economy has officially surpassed any other region in the world, bringing in a new era of Asian leadership.",
"keywords": "",
"snippet": "We recently compiled a report on the 15 most respected countries in Asia in 2024 and in this article we will look at the most respected country.\n\nToday’s econ...",
"url": "https://www.insidermonkey.com/blog/the-most-respected-country-in-asia-in-2024-1326707/",
"image_url": "https://d2gr5kl7dt2z3t.cloudfront.net/blog/wp-content/uploads/2023/04/19071222/jezael-melgoza-alY6_OpdwRQ-unsplash.jpg",
"language": "en",
"published_at": "2024-07-27T01:26:41.000000Z",
"source": "insidermonkey.com",
"relevance_score": null,
"entities": [
{
"symbol": "AAPL.MX",
"name": "Apple Inc.",
"exchange": null,
"exchange_long": null,
"country": "mx",
"type": "equity",
"industry": "Technology",
"match_score": 15.024959,
"sentiment_score": 0.489567,
"highlights": [
{
"highlight": "<em>Apple</em> <em>Inc</em>. (NASDAQ:AAPL), for example, is deepening its engagement with China while also expanding production in Southeast Asia and India, highlighting the company’s delicate balancing act between political pressures and business needs.",
"sentiment": 0.2263,
"highlighted_in": "main_text"
},
{
"highlight": "As <em>Apple</em> <em>Inc</em>. (NASDAQ:AAPL) accelerates its supply chain shift to Southeast Asia amid the ongoing U.S.-China tech conflict, its ties with China continue to strengthen. Moreover, CEO Tim Cook emphasized the company’s success in South Asian markets, achieving all-time records in countries such as India.",
"sentiment": 0.5719,
"highlighted_in": "main_text"
},
{
"highlight": "Analysts predict that in the coming years, <em>Apple</em> <em>Inc</em>. (NASDAQ:AAPL) will increasingly focus on countries like Indonesia, Malaysia, and India, which are expected to become significant contributors to the company’s global market share.",
"sentiment": 0.6705,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "TSMN.MX",
"name": "Taiwan Semiconductor Manufacturing Company Limited",
"exchange": null,
"exchange_long": null,
"country": "mx",
"type": "equity",
"industry": "Technology",
"match_score": 28.219477,
"sentiment_score": 0,
"highlights": [
{
"highlight": "The continent is home to some of the world’s largest corporations, including semiconductor giant <em>Taiwan</em> <em>Semiconductor</em> <em>Manufacturing</em> <em>Company</em> <em>Limited</em> (NYSE:TSM). Back in 2000, Asia accounted for less than one-third of the world’s GDP in purchasing power parity terms.",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
}
],
"similar": []
},
{
"uuid": "5cd66096-fb4a-4d48-b938-d99a5859fd98",
"title": "15 Most Respected Countries in Asia in 2024",
"description": "Today's economic and political disruptions frequently position Asia at the forefront, as its economy has officially surpassed any other region in the world, bringing in a new era of Asian leadership.",
"keywords": "",
"snippet": "In this article, we will look at the 15 most respected countries in Asia in 2024.\n\nToday’s economic and political disruptions frequently position Asia at the ...",
"url": "https://www.insidermonkey.com/blog/15-most-respected-countries-in-asia-in-2024-1321087/",
"image_url": "https://d2gr5kl7dt2z3t.cloudfront.net/blog/wp-content/uploads/2020/09/21132304/japan-217878_1280.jpg",
"language": "en",
"published_at": "2024-07-27T01:26:11.000000Z",
"source": "insidermonkey.com",
"relevance_score": null,
"entities": [
{
"symbol": "AAPL.MX",
"name": "Apple Inc.",
"exchange": null,
"exchange_long": null,
"country": "mx",
"type": "equity",
"industry": "Technology",
"match_score": 12.359999,
"sentiment_score": 0.489567,
"highlights": [
{
"highlight": "<em>Apple</em> <em>Inc</em>. (NASDAQ:AAPL), for example, is deepening its engagement with China while also expanding production in Southeast Asia and India, highlighting the company’s delicate balancing act between political pressures and business needs.",
"sentiment": 0.2263,
"highlighted_in": "main_text"
},
{
"highlight": "As <em>Apple</em> <em>Inc</em>. (NASDAQ:AAPL) accelerates its supply chain shift to Southeast Asia amid the ongoing U.S.-China tech conflict, its ties with China continue to strengthen. Moreover, CEO Tim Cook emphasized the company’s success in South Asian markets, achieving all-time records in countries such as India.",
"sentiment": 0.5719,
"highlighted_in": "main_text"
},
{
"highlight": "Analysts predict that in the coming years, <em>Apple</em> <em>Inc</em>. (NASDAQ:AAPL) will increasingly focus on countries like Indonesia, Malaysia, and India, which are expected to become significant contributors to the company’s global market share.",
"sentiment": 0.6705,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "MSFT.MX",
"name": "Microsoft Corporation",
"exchange": null,
"exchange_long": null,
"country": "mx",
"type": "equity",
"industry": "Technology",
"match_score": 8.457117,
"sentiment_score": 0.63485,
"highlights": [
{
"highlight": "Strengthening the country’s presence on the global stage, <em>Microsoft</em> <em>Corporation</em> recently announced plans to invest $1.7 billion in artificial intelligence and cloud services in Indonesia.",
"sentiment": 0.743,
"highlighted_in": "main_text"
},
{
"highlight": "Unveiled by <em>Microsoft</em> CEO Satya Nadella, the plan includes training 840,000 Indonesians in AI and providing support for the country’s growing community of tech developers. This marks Microsoft’s largest investment in Indonesia in its nearly three-decade history in the Southeast Asian nation.\n\n9.",
"sentiment": 0.5267,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "TSMN.MX",
"name": "Taiwan Semiconductor Manufacturing Company Limited",
"exchange": null,
"exchange_long": null,
"country": "mx",
"type": "equity",
"industry": "Technology",
"match_score": 20.80613,
"sentiment_score": 0,
"highlights": [
{
"highlight": "The continent is home to some of the world’s largest corporations, including semiconductor giant <em>Taiwan</em> <em>Semiconductor</em> <em>Manufacturing</em> <em>Company</em> <em>Limited</em> (NYSE:TSM). Back in 2000, Asia accounted for less than one-third of the world’s GDP in purchasing power parity terms.",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
}
],
"similar": []
},
{
"uuid": "919f5e62-592c-44b6-8acb-6dcf9aae7155",
"title": "UCB SA (UCBJF) Q2 2024 Earnings Call Transcript Highlights: Strong Sales Growth Amid Increased Investments",
"description": "Net Sales Growth: +11% or +13% at constant exchange rates.Adjusted EBITDA: 23%, slightly in decline versus last year.BIMZELX Sales (US): EUR85 million for the",
"keywords": "GuruFocus, Article, News, GuruFocus Research, UCBJF",
"snippet": "Release Date: July 25, 2024\n\nFor the complete transcript of the earnings call, please refer to the full earnings call transcript.\n\nPositive Points\n\nUCB SA (UCBJ...",
"url": "https://www.gurufocus.com/news/2483673/ucb-sa-ucbjf-q2-2024-earnings-call-transcript-highlights-strong-sales-growth-amid-increased-investments",
"image_url": "https://static.gurufocus.com/logos/0C00000WQ0.png?5",
"language": "en",
"published_at": "2024-07-27T01:00:29.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "UCBN.MX",
"name": "UCB SA",
"exchange": null,
"exchange_long": null,
"country": "mx",
"type": "equity",
"industry": "N/A",
"match_score": 84.17598,
"sentiment_score": 0.47264,
"highlights": [
{
"highlight": "Positive Points\n\n<em>UCB</em> <em>SA</em> (UCBJF, Financial) reported a significant turnaround in net sales, achieving a growth of 11% or 13% at constant exchange rates, compared to a decline of 12% or 14% the previous year.",
"sentiment": 0.7906,
"highlighted_in": "main_text"
},
{
"highlight": "<em>UCB</em> <em>SA</em> (UCBJF) achieved five new approvals in various regions, including BIMZELX for hidradenitis suppurativa in Europe and ankylosing spondylarthritis in China.\n\nThe company has a strong pipeline with 10 new patient populations in 10 projects expected to deliver significant news flow in the second half of 2024.",
"sentiment": 0.6249,
"highlighted_in": "main_text"
},
{
"highlight": "<em>UCB</em> <em>SA</em> (UCBJF) improved its ESG rating by increasing product availability in low and medium-income countries and enhancing access to its products, reaching 82% in June.",
"sentiment": 0.4215,
"highlighted_in": "main_text"
},
{
"highlight": "Negative Points\n\nDespite the positive sales growth, <em>UCB</em> <em>SA</em> (UCBJF) reported a decline in adjusted EBITDA to 23%, attributed to substantial investments behind new product launches.",
"sentiment": -0.2644,
"highlighted_in": "main_text"
},
{
"highlight": "<em>UCB</em> <em>SA</em> (UCBJF) Q2 2024 Earnings Call Transcript Highlights: Strong Sales Growth Amid Increased Investments",
"sentiment": 0.7906,
"highlighted_in": "title"
}
]
}
],
"similar": []
},
{
"uuid": "46dde3ac-6e95-4b48-a315-3fa431a17afa",
"title": "Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Enphase, Hertz, Fat Brands, and Charge and Encourages Investors to Contact the Firm",
"description": "NEW YORK, July 26, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that...",
"keywords": "Bragar Eagel & Squire, Enphase, ENPH, Hertz, HTZ, Fat Brands, FAT, Charge, CRGEQ, CRGE, securities, class action, stockholder rights, litigate, lawyer, legal, lawsuit, invest, a, Class Action",
"snippet": "NEW YORK, July 26, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actio...",
"url": "https://www.globenewswire.com/news-release/2024/07/27/2919922/0/en/Bragar-Eagel-Squire-P-C-Reminds-Investors-That-Class-Action-Lawsuits-Have-Been-Filed-Against-Enphase-Hertz-Fat-Brands-and-Charge-and-Encourages-Investors-to-Contact-the-Firm.html",
"image_url": "https://ml.globenewswire.com/Resource/Download/29481954-f2ff-4756-b5a9-d982a6497bd0",
"language": "en",
"published_at": "2024-07-27T01:00:00.000000Z",
"source": "globenewswire.com",
"relevance_score": null,
"entities": [
{
"symbol": "ENPH.MX",
"name": "Enphase Energy, Inc.",
"exchange": null,
"exchange_long": null,
"country": "mx",
"type": "equity",
"industry": "Technology",
"match_score": 15.62631,
"sentiment_score": 0,
"highlights": [
{
"highlight": "., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of <em>Enphase</em> <em>Energy</em>, <em>Inc</em>. (NASDAQ: ENPH), Hertz Global Holdings, Inc. (NASDAQ: HTZ), FAT Brands Inc. (NASDAQ: FAT), and Charge Enterprises (NASDAQ: CRGEQ).",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Enphase</em> <em>Energy</em>, <em>Inc</em>.",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
}
],
"similar": [
{
"uuid": "bf9b344e-63ee-4966-86eb-74de7afdb1e3",
"title": "DEADLINE ALERT: Enphase Energy, Inc. Investors – Class action lawsuit filed on behalf of investors; the Portnoy Law Firm",
"description": "Investors can contact the law firm at no cost to learn more about recovering their losses. LOS ANGELES, July 26, 2024 (GLOBE NEWSWIRE) -- The Portnoy...",
"keywords": "Portnoy Law, $ENPH, Enphase Energy Inc, Enphase, Securities Fraud, Securities Litigation, Class Action, Recover your Losses, Portnoy Law Firm",
"snippet": "Investors can contact the law firm at no cost to learn more about recovering their losses.\n\n\n\nLOS ANGELES, July 26, 2024 (GLOBE NEWSWIRE) -- The Portnoy Law Fir...",
"url": "https://www.globenewswire.com/news-release/2024/07/26/2919917/0/en/DEADLINE-ALERT-Enphase-Energy-Inc-Investors-Class-action-lawsuit-filed-on-behalf-of-investors-the-Portnoy-Law-Firm.html",
"image_url": "https://ml.globenewswire.com/Resource/Download/ea0dd9c0-6e41-4d5a-ad27-b277677af6df",
"language": "en",
"published_at": "2024-07-26T23:58:00.000000Z",
"source": "globenewswire.com",
"relevance_score": null,
"entities": [
{
"symbol": "ENPH",
"name": "Enphase Energy, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Technology",
"match_score": 118.694626,
"sentiment_score": -0.06205,
"highlights": [
{
"highlight": "LOS ANGELES, July 26, 2024 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises <em>Enphase</em> <em>Energy</em>, <em>Inc</em>. (\"Enphase\" or the \"Company\") (<em>NASDAQ</em>: <em>ENPH</em>) investors who suffered substantial losses to contact Lesley Portnoy, Esq.\n\nInvestors are encouraged to contact attorney Lesley F.",
"sentiment": -0.3818,
"highlighted_in": "main_text"
},
{
"highlight": "DEADLINE ALERT: <em>Enphase</em> <em>Energy</em>, <em>Inc</em>. Investors – Class action lawsuit filed on behalf of investors; the Portnoy Law Firm",
"sentiment": 0.2577,
"highlighted_in": "title"
}
]
},
{
"symbol": "ENPH.MX",
"name": "Enphase Energy, Inc.",
"exchange": null,
"exchange_long": null,
"country": "mx",
"type": "equity",
"industry": "Technology",
"match_score": 97.4597,
"sentiment_score": -0.06205,
"highlights": [
{
"highlight": "LOS ANGELES, July 26, 2024 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises <em>Enphase</em> <em>Energy</em>, <em>Inc</em>. (\"Enphase\" or the \"Company\") (NASDAQ: ENPH) investors who suffered substantial losses to contact Lesley Portnoy, Esq.\n\nInvestors are encouraged to contact attorney Lesley F.",
"sentiment": -0.3818,
"highlighted_in": "main_text"
},
{
"highlight": "DEADLINE ALERT: <em>Enphase</em> <em>Energy</em>, <em>Inc</em>. Investors – Class action lawsuit filed on behalf of investors; the Portnoy Law Firm",
"sentiment": 0.2577,
"highlighted_in": "title"
}
]
},
{
"symbol": "0QYE.L",
"name": "Enphase Energy, Inc.",
"exchange": null,
"exchange_long": null,
"country": "gb",
"type": "equity",
"industry": "N/A",
"match_score": 97.44791,
"sentiment_score": -0.06205,
"highlights": [
{
"highlight": "LOS ANGELES, July 26, 2024 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises <em>Enphase</em> <em>Energy</em>, <em>Inc</em>. (\"Enphase\" or the \"Company\") (NASDAQ: ENPH) investors who suffered substantial losses to contact Lesley Portnoy, Esq.\n\nInvestors are encouraged to contact attorney Lesley F.",
"sentiment": -0.3818,
"highlighted_in": "main_text"
},
{
"highlight": "DEADLINE ALERT: <em>Enphase</em> <em>Energy</em>, <em>Inc</em>. Investors – Class action lawsuit filed on behalf of investors; the Portnoy Law Firm",
"sentiment": 0.2577,
"highlighted_in": "title"
}
]
}
]
},
{
"uuid": "87c03364-632e-4b00-8d7d-2ef94588a857",
"title": "ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Lamb Weston Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – LW",
"description": "NEW YORK, July 26, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Lamb Weston...",
"keywords": "The Rosen Law Firm PA, Lamb Weston Holdings, Inc., LW, Class Action",
"snippet": "NEW YORK, July 26, 2024 (GLOBE NEWSWIRE) --\n\nWHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Lamb Weston Holdings,...",
"url": "https://www.globenewswire.com/news-release/2024/07/26/2919901/673/en/ROSEN-GLOBAL-INVESTOR-COUNSEL-Encourages-Lamb-Weston-Holdings-Inc-Investors-to-Secure-Counsel-Before-Important-Deadline-in-Securities-Class-Action-LW.html",
"image_url": "https://ml.globenewswire.com/Resource/Download/745335af-3a3a-4fb5-84c0-fdedc9adf092",
"language": "en",
"published_at": "2024-07-26T21:31:00.000000Z",
"source": "globenewswire.com",
"relevance_score": null,
"entities": [
{
"symbol": "LW",
"name": "Lamb Weston Holdings, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Consumer Defensive",
"match_score": 154.78583,
"sentiment_score": 0.50485,
"highlights": [
{
"highlight": "NEW YORK, July 26, 2024 (GLOBE NEWSWIRE) --\n\nWHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of <em>Lamb</em> <em>Weston</em> <em>Holdings</em>, <em>Inc</em>. (<em>NYSE</em>: <em>LW</em>) between July 25, 2023 and April 3, 2024, both dates inclusive (the “Class Period”), of the important August 12, 2024 lead plaintiff deadline.",
"sentiment": 0.2023,
"highlighted_in": "main_text"
},
{
"highlight": "ROSEN, GLOBAL INVESTOR COUNSEL, Encourages <em>Lamb</em> <em>Weston</em> <em>Holdings</em>, <em>Inc</em>. Investors to Secure Counsel Before Important Deadline in Securities Class Action – LW",
"sentiment": 0.8074,
"highlighted_in": "title"
}
]
},
{
"symbol": "LW.MX",
"name": "Lamb Weston Holdings, Inc.",
"exchange": null,
"exchange_long": null,
"country": "mx",
"type": "equity",
"industry": "Consumer Defensive",
"match_score": 138.58682,
"sentiment_score": 0.50485,
"highlights": [
{
"highlight": "NEW YORK, July 26, 2024 (GLOBE NEWSWIRE) --\n\nWHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of <em>Lamb</em> <em>Weston</em> <em>Holdings</em>, <em>Inc</em>. (NYSE: LW) between July 25, 2023 and April 3, 2024, both dates inclusive (the “Class Period”), of the important August 12, 2024 lead plaintiff deadline.",
"sentiment": 0.2023,
"highlighted_in": "main_text"
},
{
"highlight": "ROSEN, GLOBAL INVESTOR COUNSEL, Encourages <em>Lamb</em> <em>Weston</em> <em>Holdings</em>, <em>Inc</em>. Investors to Secure Counsel Before Important Deadline in Securities Class Action – LW",
"sentiment": 0.8074,
"highlighted_in": "title"
}
]
}
]
}
]
},
{
"uuid": "cda70037-3c19-467c-8554-c92f88afcc96",
"title": "Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against NIKE, FutureFuel, SeaStar, and Bolt and Encourages Investors to Contact the Firm",
"description": "NEW YORK, July 26, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that...",
"keywords": "Bragar Eagel & Squire, Nike, NKE, FutureFuel, FF, SeaStar, ICU, Bolt, securities, class action, stockholder rights, legal, lawyer, lawsuit, litigate, complaint, share, stock, a, Class Action",
"snippet": "NEW YORK, July 26, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actio...",
"url": "https://www.globenewswire.com/news-release/2024/07/27/2919925/0/en/Bragar-Eagel-Squire-P-C-Reminds-Investors-That-Class-Action-Lawsuits-Have-Been-Filed-Against-NIKE-FutureFuel-SeaStar-and-Bolt-and-Encourages-Investors-to-Contact-the-Firm.html",
"image_url": "https://ml.globenewswire.com/Resource/Download/29481954-f2ff-4756-b5a9-d982a6497bd0",
"language": "en",
"published_at": "2024-07-27T01:00:00.000000Z",
"source": "globenewswire.com",
"relevance_score": null,
"entities": [
{
"symbol": "NKE.MX",
"name": "NIKE, Inc.",
"exchange": null,
"exchange_long": null,
"country": "mx",
"type": "equity",
"industry": "Consumer Cyclical",
"match_score": 7.312237,
"sentiment_score": 0,
"highlights": [
{
"highlight": "., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of <em>NIKE</em>, <em>Inc</em>. (NYSE: NKE), FutureFuel Corp. (NYSE: FF), SeaStar Medical Holding Corporation (NASDAQ: ICU) and Bolt Biotherapeutics (NASDAQ: BOLT).",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>NIKE</em>, <em>Inc</em>. (NYSE: NKE)\n\nClass Period: March 19, 2021 - March 21, 2024\n\nLead Plaintiff Deadline: August 19, 2024\n\nThe Class Period begins on March 19, 2021, in connection with NIKE’s announcement of its financial results for the third quarter of fiscal year 2021, and related investor earnings call.",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
}
],
"similar": [
{
"uuid": "406247c6-5686-4cc9-8886-994e7aaf51ae",
"title": "DEXCOM ALERT: Bragar Eagel & Squire, P.C. is Investigating DexCom, Inc. on Behalf of DexCom Stockholders and Encourages Investors to Contact the Firm",
"description": "NEW YORK, July 26, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating...",
"keywords": "Bragar Eagel & Squire, DexCom, DXCM, securities, class action, stockholder rights, legal, lawyer, lawsuit, litigate, investigation, share, stock, investor, invest, a, Class Action",
"snippet": "NEW YORK, July 26, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims ...",
"url": "https://www.globenewswire.com/news-release/2024/07/27/2919924/0/en/DEXCOM-ALERT-Bragar-Eagel-Squire-P-C-is-Investigating-DexCom-Inc-on-Behalf-of-DexCom-Stockholders-and-Encourages-Investors-to-Contact-the-Firm.html",
"image_url": "https://ml.globenewswire.com/Resource/Download/29481954-f2ff-4756-b5a9-d982a6497bd0",
"language": "en",
"published_at": "2024-07-27T01:00:00.000000Z",
"source": "globenewswire.com",
"relevance_score": null,
"entities": [
{
"symbol": "DXCM",
"name": "DexCom, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 101.81426,
"sentiment_score": 0.299233,
"highlights": [
{
"highlight": "., a nationally recognized stockholder rights law firm, is investigating potential claims against <em>DexCom</em>, <em>Inc</em>. (“<em>DexCom</em>” or the “Company”) (<em>NASDAQ</em>: <em>DXCM</em>) on behalf of <em>DexCom</em> stockholders. Our investigation concerns whether <em>DexCom</em> has violated the federal securities laws and/or engaged in other unlawful business practices.",
"sentiment": 0.128,
"highlighted_in": "main_text"
},
{
"highlight": "On July 25, 2024, after the closure of market trading, <em>DexCom</em> issued a press release announcing its financial results for the second quarter of 2024. The Company reported revenue figures amounting to $1.004 billion. However, the press release conveyed that the Company’s performance did not meet its established high standards of execution.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Furthermore, <em>DexCom</em> revised its revenue guidance for the full fiscal year of 2024, projecting a revenue range between $4 billion and $4.05 billion. This adjustment was attributed to \"certain unique items impacting 2024 seasonality,\" which have been identified as factors influencing the Company’s financial outlook.",
"sentiment": 0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "Following this news, <em>DexCom</em> stock was trading down 39% during pre-market trading on July 26, 2024.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "If you purchased or otherwise acquired <em>DexCom</em> shares and suffered a loss, are a long-term stockholder, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Brandon Walker or Marion Passmore by email at investigations",
"sentiment": 0.6908,
"highlighted_in": "main_text"
},
{
"highlight": "<em>DEXCOM</em> ALERT: Bragar Eagel & Squire, P.C. is Investigating <em>DexCom</em>, <em>Inc</em>. on Behalf of <em>DexCom</em> Stockholders and Encourages Investors to Contact the Firm",
"sentiment": 0.7034,
"highlighted_in": "title"
}
]
},
{
"symbol": "DC4.DE",
"name": "DexCom, Inc.",
"exchange": null,
"exchange_long": null,
"country": "de",
"type": "equity",
"industry": "Healthcare",
"match_score": 80.999374,
"sentiment_score": 0.299233,
"highlights": [
{
"highlight": "., a nationally recognized stockholder rights law firm, is investigating potential claims against <em>DexCom</em>, <em>Inc</em>. (“<em>DexCom</em>” or the “Company”) (NASDAQ: DXCM) on behalf of <em>DexCom</em> stockholders. Our investigation concerns whether <em>DexCom</em> has violated the federal securities laws and/or engaged in other unlawful business practices.",
"sentiment": 0.128,
"highlighted_in": "main_text"
},
{
"highlight": "On July 25, 2024, after the closure of market trading, <em>DexCom</em> issued a press release announcing its financial results for the second quarter of 2024. The Company reported revenue figures amounting to $1.004 billion. However, the press release conveyed that the Company’s performance did not meet its established high standards of execution.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Furthermore, <em>DexCom</em> revised its revenue guidance for the full fiscal year of 2024, projecting a revenue range between $4 billion and $4.05 billion. This adjustment was attributed to \"certain unique items impacting 2024 seasonality,\" which have been identified as factors influencing the Company’s financial outlook.",
"sentiment": 0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "Following this news, <em>DexCom</em> stock was trading down 39% during pre-market trading on July 26, 2024.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "If you purchased or otherwise acquired <em>DexCom</em> shares and suffered a loss, are a long-term stockholder, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Brandon Walker or Marion Passmore by email at investigations",
"sentiment": 0.6908,
"highlighted_in": "main_text"
},
{
"highlight": "<em>DEXCOM</em> ALERT: Bragar Eagel & Squire, P.C. is Investigating <em>DexCom</em>, <em>Inc</em>. on Behalf of <em>DexCom</em> Stockholders and Encourages Investors to Contact the Firm",
"sentiment": 0.7034,
"highlighted_in": "title"
}
]
},
{
"symbol": "DXCM.MX",
"name": "DexCom, Inc.",
"exchange": null,
"exchange_long": null,
"country": "mx",
"type": "equity",
"industry": "Healthcare",
"match_score": 80.99518,
"sentiment_score": 0.299233,
"highlights": [
{
"highlight": "., a nationally recognized stockholder rights law firm, is investigating potential claims against <em>DexCom</em>, <em>Inc</em>. (“<em>DexCom</em>” or the “Company”) (NASDAQ: DXCM) on behalf of <em>DexCom</em> stockholders. Our investigation concerns whether <em>DexCom</em> has violated the federal securities laws and/or engaged in other unlawful business practices.",
"sentiment": 0.128,
"highlighted_in": "main_text"
},
{
"highlight": "On July 25, 2024, after the closure of market trading, <em>DexCom</em> issued a press release announcing its financial results for the second quarter of 2024. The Company reported revenue figures amounting to $1.004 billion. However, the press release conveyed that the Company’s performance did not meet its established high standards of execution.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Furthermore, <em>DexCom</em> revised its revenue guidance for the full fiscal year of 2024, projecting a revenue range between $4 billion and $4.05 billion. This adjustment was attributed to \"certain unique items impacting 2024 seasonality,\" which have been identified as factors influencing the Company’s financial outlook.",
"sentiment": 0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "Following this news, <em>DexCom</em> stock was trading down 39% during pre-market trading on July 26, 2024.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "If you purchased or otherwise acquired <em>DexCom</em> shares and suffered a loss, are a long-term stockholder, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Brandon Walker or Marion Passmore by email at investigations",
"sentiment": 0.6908,
"highlighted_in": "main_text"
},
{
"highlight": "<em>DEXCOM</em> ALERT: Bragar Eagel & Squire, P.C. is Investigating <em>DexCom</em>, <em>Inc</em>. on Behalf of <em>DexCom</em> Stockholders and Encourages Investors to Contact the Firm",
"sentiment": 0.7034,
"highlighted_in": "title"
}
]
},
{
"symbol": "0A4M.L",
"name": "DexCom, Inc.",
"exchange": null,
"exchange_long": null,
"country": "gb",
"type": "equity",
"industry": "N/A",
"match_score": 80.99131,
"sentiment_score": 0.299233,
"highlights": [
{
"highlight": "., a nationally recognized stockholder rights law firm, is investigating potential claims against <em>DexCom</em>, <em>Inc</em>. (“<em>DexCom</em>” or the “Company”) (NASDAQ: DXCM) on behalf of <em>DexCom</em> stockholders. Our investigation concerns whether <em>DexCom</em> has violated the federal securities laws and/or engaged in other unlawful business practices.",
"sentiment": 0.128,
"highlighted_in": "main_text"
},
{
"highlight": "On July 25, 2024, after the closure of market trading, <em>DexCom</em> issued a press release announcing its financial results for the second quarter of 2024. The Company reported revenue figures amounting to $1.004 billion. However, the press release conveyed that the Company’s performance did not meet its established high standards of execution.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Furthermore, <em>DexCom</em> revised its revenue guidance for the full fiscal year of 2024, projecting a revenue range between $4 billion and $4.05 billion. This adjustment was attributed to \"certain unique items impacting 2024 seasonality,\" which have been identified as factors influencing the Company’s financial outlook.",
"sentiment": 0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "Following this news, <em>DexCom</em> stock was trading down 39% during pre-market trading on July 26, 2024.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "If you purchased or otherwise acquired <em>DexCom</em> shares and suffered a loss, are a long-term stockholder, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Brandon Walker or Marion Passmore by email at investigations",
"sentiment": 0.6908,
"highlighted_in": "main_text"
},
{
"highlight": "<em>DEXCOM</em> ALERT: Bragar Eagel & Squire, P.C. is Investigating <em>DexCom</em>, <em>Inc</em>. on Behalf of <em>DexCom</em> Stockholders and Encourages Investors to Contact the Firm",
"sentiment": 0.7034,
"highlighted_in": "title"
}
]
},
{
"symbol": "D1EX34.SA",
"name": "DexCom, Inc.",
"exchange": null,
"exchange_long": null,
"country": "br",
"type": "equity",
"industry": "Healthcare",
"match_score": 81.02235,
"sentiment_score": 0.299233,
"highlights": [
{
"highlight": "., a nationally recognized stockholder rights law firm, is investigating potential claims against <em>DexCom</em>, <em>Inc</em>. (“<em>DexCom</em>” or the “Company”) (NASDAQ: DXCM) on behalf of <em>DexCom</em> stockholders. Our investigation concerns whether <em>DexCom</em> has violated the federal securities laws and/or engaged in other unlawful business practices.",
"sentiment": 0.128,
"highlighted_in": "main_text"
},
{
"highlight": "On July 25, 2024, after the closure of market trading, <em>DexCom</em> issued a press release announcing its financial results for the second quarter of 2024. The Company reported revenue figures amounting to $1.004 billion. However, the press release conveyed that the Company’s performance did not meet its established high standards of execution.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Furthermore, <em>DexCom</em> revised its revenue guidance for the full fiscal year of 2024, projecting a revenue range between $4 billion and $4.05 billion. This adjustment was attributed to \"certain unique items impacting 2024 seasonality,\" which have been identified as factors influencing the Company’s financial outlook.",
"sentiment": 0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "Following this news, <em>DexCom</em> stock was trading down 39% during pre-market trading on July 26, 2024.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "If you purchased or otherwise acquired <em>DexCom</em> shares and suffered a loss, are a long-term stockholder, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Brandon Walker or Marion Passmore by email at investigations",
"sentiment": 0.6908,
"highlighted_in": "main_text"
},
{
"highlight": "<em>DEXCOM</em> ALERT: Bragar Eagel & Squire, P.C. is Investigating <em>DexCom</em>, <em>Inc</em>. on Behalf of <em>DexCom</em> Stockholders and Encourages Investors to Contact the Firm",
"sentiment": 0.7034,
"highlighted_in": "title"
}
]
}
]
},
{
"uuid": "c9476cdb-d3d3-497b-b7b3-030c947eec3b",
"title": "Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against CVS, Walgreens, and American Airlines and Encourages Investors to Contact the Firm",
"description": "NEW YORK, July 26, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that...",
"keywords": "Bragar Eagel & Squire, CVS, Walgreens Boots Alliance, WBA, American Airlines, AAL, securities, class action, stockholder rights, legal, lawyer, litigate, lawsuit, a, Class Action",
"snippet": "NEW YORK, July 26, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actio...",
"url": "https://www.globenewswire.com/news-release/2024/07/27/2919923/0/en/Bragar-Eagel-Squire-P-C-Reminds-Investors-That-Class-Action-Lawsuits-Have-Been-Filed-Against-CVS-Walgreens-and-American-Airlines-and-Encourages-Investors-to-Contact-the-Firm.html",
"image_url": "https://ml.globenewswire.com/Resource/Download/29481954-f2ff-4756-b5a9-d982a6497bd0",
"language": "en",
"published_at": "2024-07-27T01:00:00.000000Z",
"source": "globenewswire.com",
"relevance_score": null,
"entities": [
{
"symbol": "WBA.BA",
"name": "Walgreens Boots Alliance, Inc.",
"exchange": null,
"exchange_long": null,
"country": "ar",
"type": "equity",
"industry": "N/A",
"match_score": 36.26844,
"sentiment_score": 0,
"highlights": [
{
"highlight": "., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of CVS Health Corporation (NYSE: CVS), <em>Walgreens</em> <em>Boots</em> <em>Alliance</em>, <em>Inc</em>. (NASDAQ: WBA), and American Airlines Group Inc. (NASDAQ: AAL).",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "For more information on the CVS class action go to: https://bespc.com/cases/CVS\n\n<em>Walgreens</em> <em>Boots</em> <em>Alliance</em>, <em>Inc</em>.",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "CVS.SN",
"name": "CVS Health Corporation",
"exchange": null,
"exchange_long": null,
"country": "cl",
"type": "equity",
"industry": "Healthcare",
"match_score": 22.860802,
"sentiment_score": 0.41355,
"highlights": [
{
"highlight": "., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of <em>CVS</em> <em>Health</em> <em>Corporation</em> (NYSE: CVS), Walgreens Boots Alliance, Inc. (NASDAQ: WBA), and American Airlines Group Inc. (NASDAQ: AAL).",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>CVS</em> <em>Health</em> <em>Corporation</em> (NYSE: CVS)\n\nClass Period: May 3, 2023 - April 30, 2024\n\nLead Plaintiff Deadline: September 10, 2024\n\nCVS is a healthcare company that operates through three primary segments: Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness.",
"sentiment": 0.8271,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "CVSCL.SN",
"name": "CVS Health Corporation",
"exchange": null,
"exchange_long": null,
"country": "cl",
"type": "equity",
"industry": "N/A",
"match_score": 22.860739,
"sentiment_score": 0.41355,
"highlights": [
{
"highlight": "., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of <em>CVS</em> <em>Health</em> <em>Corporation</em> (NYSE: CVS), Walgreens Boots Alliance, Inc. (NASDAQ: WBA), and American Airlines Group Inc. (NASDAQ: AAL).",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>CVS</em> <em>Health</em> <em>Corporation</em> (NYSE: CVS)\n\nClass Period: May 3, 2023 - April 30, 2024\n\nLead Plaintiff Deadline: September 10, 2024\n\nCVS is a healthcare company that operates through three primary segments: Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness.",
"sentiment": 0.8271,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "AAL",
"name": "American Airlines Group Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Industrials",
"match_score": 58.676796,
"sentiment_score": 0.12284,
"highlights": [
{
"highlight": "(NASDAQ: WBA), and <em>American</em> <em>Airlines</em> <em>Group</em> <em>Inc</em>. (<em>NASDAQ</em>: <em>AAL</em>). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "For more information on the Walgreens class action go to: https://bespc.com/cases/WBA\n\n<em>American</em> <em>Airlines</em> <em>Group</em> <em>Inc</em>. (<em>NASDAQ</em>: <em>AAL</em>)\n\nClass Period: January 25, 2024 - May 28, 2024\n\nLead Plaintiff Deadline: September 16, 2024\n\nOn May 28, 2024, after the market closed, <em>American</em> <em>Airlines</em> announced that its Chief Commercial Officer was departing.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "On this news, <em>American</em> <em>Airlines</em>’ stock price fell $1.82, or 13.5%, to close at $11.62 per share on May 29, 2024, thereby injuring investors.",
"sentiment": 0.296,
"highlighted_in": "main_text"
},
{
"highlight": "For more information on the <em>American</em> <em>Airlines</em> class action go to: https://bespc.com/cases/AAL\n\nAbout Bragar Eagel & Squire, P.C.:\n\nBragar Eagel & Squire, P.C. is a nationally recognized law firm with offices in New York, California, and South Carolina.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Reminds Investors That Class Action Lawsuits Have Been Filed Against CVS, Walgreens, and <em>American</em> <em>Airlines</em> and Encourages Investors to Contact the Firm",
"sentiment": 0.3182,
"highlighted_in": "title"
}
]
},
{
"symbol": "WBA",
"name": "Walgreens Boots Alliance, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 51.023926,
"sentiment_score": -0.098667,
"highlights": [
{
"highlight": "., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of CVS Health Corporation (NYSE: CVS), <em>Walgreens</em> <em>Boots</em> <em>Alliance</em>, <em>Inc</em>. (<em>NASDAQ</em>: <em>WBA</em>), and American Airlines Group Inc. (NASDAQ: AAL).",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "For more information on the CVS class action go to: https://bespc.com/cases/CVS\n\n<em>Walgreens</em> <em>Boots</em> <em>Alliance</em>, <em>Inc</em>.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "(<em>NASDAQ</em>: <em>WBA</em>)\n\nClass Period: October 12, 2023 and June 26, 2024\n\nLead Plaintiff Deadline: September 10, 2024\n\nThe complaint alleges that on June 27, 2024, Walgreens announced 3Q24 financial results and reduced its revenue guidance for the fourth quarter and full fiscal year 2024.",
"sentiment": -0.296,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "HCSG",
"name": "Healthcare Services Group, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 9.924631,
"sentiment_score": -0.5267,
"highlights": [
{
"highlight": "The Company stated that higher utilization of <em>healthcare</em> <em>services</em>, meaning more insurance dollars spent, weighed on its results in addition to Medicare reimbursement rate cuts that will continue to pressure CVS for the remainder of the year.",
"sentiment": -0.5267,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "CVS",
"name": "CVS Health Corporation",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 36.62262,
"sentiment_score": 0.41355,
"highlights": [
{
"highlight": "., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of <em>CVS</em> <em>Health</em> <em>Corporation</em> (<em>NYSE</em>: <em>CVS</em>), Walgreens Boots Alliance, Inc. (NASDAQ: WBA), and American Airlines Group Inc. (NASDAQ: AAL).",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>CVS</em> <em>Health</em> <em>Corporation</em> (<em>NYSE</em>: <em>CVS</em>)\n\nClass Period: May 3, 2023 - April 30, 2024\n\nLead Plaintiff Deadline: September 10, 2024\n\nCVS is a healthcare company that operates through three primary segments: Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness.",
"sentiment": 0.8271,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "A1G.DE",
"name": "American Airlines Group Inc.",
"exchange": null,
"exchange_long": null,
"country": "de",
"type": "equity",
"industry": "Industrials",
"match_score": 42.953335,
"sentiment_score": 0.12284,
"highlights": [
{
"highlight": "(NASDAQ: WBA), and <em>American</em> <em>Airlines</em> <em>Group</em> <em>Inc</em>. (NASDAQ: AAL). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "For more information on the Walgreens class action go to: https://bespc.com/cases/WBA\n\n<em>American</em> <em>Airlines</em> <em>Group</em> <em>Inc</em>. (NASDAQ: AAL)\n\nClass Period: January 25, 2024 - May 28, 2024\n\nLead Plaintiff Deadline: September 16, 2024\n\nOn May 28, 2024, after the market closed, <em>American</em> <em>Airlines</em> announced that its Chief Commercial Officer was departing.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "On this news, <em>American</em> <em>Airlines</em>’ stock price fell $1.82, or 13.5%, to close at $11.62 per share on May 29, 2024, thereby injuring investors.",
"sentiment": 0.296,
"highlighted_in": "main_text"
},
{
"highlight": "For more information on the <em>American</em> <em>Airlines</em> class action go to: https://bespc.com/cases/AAL\n\nAbout Bragar Eagel & Squire, P.C.:\n\nBragar Eagel & Squire, P.C. is a nationally recognized law firm with offices in New York, California, and South Carolina.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Reminds Investors That Class Action Lawsuits Have Been Filed Against CVS, Walgreens, and <em>American</em> <em>Airlines</em> and Encourages Investors to Contact the Firm",
"sentiment": 0.3182,
"highlighted_in": "title"
}
]
},
{
"symbol": "W8A.DE",
"name": "Walgreens Boots Alliance Inc",
"exchange": null,
"exchange_long": null,
"country": "de",
"type": "equity",
"industry": "Healthcare",
"match_score": 36.268074,
"sentiment_score": 0,
"highlights": [
{
"highlight": "., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of CVS Health Corporation (NYSE: CVS), <em>Walgreens</em> <em>Boots</em> <em>Alliance</em>, <em>Inc</em>. (NASDAQ: WBA), and American Airlines Group Inc. (NASDAQ: AAL).",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "For more information on the CVS class action go to: https://bespc.com/cases/CVS\n\n<em>Walgreens</em> <em>Boots</em> <em>Alliance</em>, <em>Inc</em>.",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "CVS.DE",
"name": "CVS Health Corporation",
"exchange": null,
"exchange_long": null,
"country": "de",
"type": "equity",
"industry": "Healthcare",
"match_score": 22.860569,
"sentiment_score": 0.41355,
"highlights": [
{
"highlight": "., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of <em>CVS</em> <em>Health</em> <em>Corporation</em> (NYSE: CVS), Walgreens Boots Alliance, Inc. (NASDAQ: WBA), and American Airlines Group Inc. (NASDAQ: AAL).",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>CVS</em> <em>Health</em> <em>Corporation</em> (NYSE: CVS)\n\nClass Period: May 3, 2023 - April 30, 2024\n\nLead Plaintiff Deadline: September 10, 2024\n\nCVS is a healthcare company that operates through three primary segments: Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness.",
"sentiment": 0.8271,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "AAL.MX",
"name": "American Airlines Group Inc.",
"exchange": null,
"exchange_long": null,
"country": "mx",
"type": "equity",
"industry": "Industrials",
"match_score": 42.953575,
"sentiment_score": 0.12284,
"highlights": [
{
"highlight": "(NASDAQ: WBA), and <em>American</em> <em>Airlines</em> <em>Group</em> <em>Inc</em>. (NASDAQ: AAL). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "For more information on the Walgreens class action go to: https://bespc.com/cases/WBA\n\n<em>American</em> <em>Airlines</em> <em>Group</em> <em>Inc</em>. (NASDAQ: AAL)\n\nClass Period: January 25, 2024 - May 28, 2024\n\nLead Plaintiff Deadline: September 16, 2024\n\nOn May 28, 2024, after the market closed, <em>American</em> <em>Airlines</em> announced that its Chief Commercial Officer was departing.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "On this news, <em>American</em> <em>Airlines</em>’ stock price fell $1.82, or 13.5%, to close at $11.62 per share on May 29, 2024, thereby injuring investors.",
"sentiment": 0.296,
"highlighted_in": "main_text"
},
{
"highlight": "For more information on the <em>American</em> <em>Airlines</em> class action go to: https://bespc.com/cases/AAL\n\nAbout Bragar Eagel & Squire, P.C.:\n\nBragar Eagel & Squire, P.C. is a nationally recognized law firm with offices in New York, California, and South Carolina.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Reminds Investors That Class Action Lawsuits Have Been Filed Against CVS, Walgreens, and <em>American</em> <em>Airlines</em> and Encourages Investors to Contact the Firm",
"sentiment": 0.3182,
"highlighted_in": "title"
}
]
},
{
"symbol": "WBA.MX",
"name": "Walgreens Boots Alliance, Inc.",
"exchange": null,
"exchange_long": null,
"country": "mx",
"type": "equity",
"industry": "Healthcare",
"match_score": 36.268013,
"sentiment_score": 0,
"highlights": [
{
"highlight": "., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of CVS Health Corporation (NYSE: CVS), <em>Walgreens</em> <em>Boots</em> <em>Alliance</em>, <em>Inc</em>. (NASDAQ: WBA), and American Airlines Group Inc. (NASDAQ: AAL).",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "For more information on the CVS class action go to: https://bespc.com/cases/CVS\n\n<em>Walgreens</em> <em>Boots</em> <em>Alliance</em>, <em>Inc</em>.",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "CVS.MX",
"name": "CVS Health Corporation",
"exchange": null,
"exchange_long": null,
"country": "mx",
"type": "equity",
"industry": "Healthcare",
"match_score": 22.86007,
"sentiment_score": 0.41355,
"highlights": [
{
"highlight": "., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of <em>CVS</em> <em>Health</em> <em>Corporation</em> (NYSE: CVS), Walgreens Boots Alliance, Inc. (NASDAQ: WBA), and American Airlines Group Inc. (NASDAQ: AAL).",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>CVS</em> <em>Health</em> <em>Corporation</em> (NYSE: CVS)\n\nClass Period: May 3, 2023 - April 30, 2024\n\nLead Plaintiff Deadline: September 10, 2024\n\nCVS is a healthcare company that operates through three primary segments: Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness.",
"sentiment": 0.8271,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "0HE6.L",
"name": "American Airlines Group Inc.",
"exchange": null,
"exchange_long": null,
"country": "gb",
"type": "equity",
"industry": "N/A",
"match_score": 42.953804,
"sentiment_score": 0.12284,
"highlights": [
{
"highlight": "(NASDAQ: WBA), and <em>American</em> <em>Airlines</em> <em>Group</em> <em>Inc</em>. (NASDAQ: AAL). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "For more information on the Walgreens class action go to: https://bespc.com/cases/WBA\n\n<em>American</em> <em>Airlines</em> <em>Group</em> <em>Inc</em>. (NASDAQ: AAL)\n\nClass Period: January 25, 2024 - May 28, 2024\n\nLead Plaintiff Deadline: September 16, 2024\n\nOn May 28, 2024, after the market closed, <em>American</em> <em>Airlines</em> announced that its Chief Commercial Officer was departing.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "On this news, <em>American</em> <em>Airlines</em>’ stock price fell $1.82, or 13.5%, to close at $11.62 per share on May 29, 2024, thereby injuring investors.",
"sentiment": 0.296,
"highlighted_in": "main_text"
},
{
"highlight": "For more information on the <em>American</em> <em>Airlines</em> class action go to: https://bespc.com/cases/AAL\n\nAbout Bragar Eagel & Squire, P.C.:\n\nBragar Eagel & Squire, P.C. is a nationally recognized law firm with offices in New York, California, and South Carolina.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Reminds Investors That Class Action Lawsuits Have Been Filed Against CVS, Walgreens, and <em>American</em> <em>Airlines</em> and Encourages Investors to Contact the Firm",
"sentiment": 0.3182,
"highlighted_in": "title"
}
]
},
{
"symbol": "0HRS.L",
"name": "CVS Health Corporation",
"exchange": null,
"exchange_long": null,
"country": "gb",
"type": "equity",
"industry": "N/A",
"match_score": 22.859858,
"sentiment_score": 0.41355,
"highlights": [
{
"highlight": "., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of <em>CVS</em> <em>Health</em> <em>Corporation</em> (NYSE: CVS), Walgreens Boots Alliance, Inc. (NASDAQ: WBA), and American Airlines Group Inc. (NASDAQ: AAL).",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>CVS</em> <em>Health</em> <em>Corporation</em> (NYSE: CVS)\n\nClass Period: May 3, 2023 - April 30, 2024\n\nLead Plaintiff Deadline: September 10, 2024\n\nCVS is a healthcare company that operates through three primary segments: Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness.",
"sentiment": 0.8271,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "0LSZ.L",
"name": "Walgreens Boots Alliance, Inc.",
"exchange": null,
"exchange_long": null,
"country": "gb",
"type": "equity",
"industry": "N/A",
"match_score": 36.267746,
"sentiment_score": 0,
"highlights": [
{
"highlight": "., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of CVS Health Corporation (NYSE: CVS), <em>Walgreens</em> <em>Boots</em> <em>Alliance</em>, <em>Inc</em>. (NASDAQ: WBA), and American Airlines Group Inc. (NASDAQ: AAL).",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "For more information on the CVS class action go to: https://bespc.com/cases/CVS\n\n<em>Walgreens</em> <em>Boots</em> <em>Alliance</em>, <em>Inc</em>.",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "AALL34.SA",
"name": "American Airlines Group Inc.",
"exchange": null,
"exchange_long": null,
"country": "br",
"type": "equity",
"industry": "Industrials",
"match_score": 42.951447,
"sentiment_score": 0.12284,
"highlights": [
{
"highlight": "(NASDAQ: WBA), and <em>American</em> <em>Airlines</em> <em>Group</em> <em>Inc</em>. (NASDAQ: AAL). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "For more information on the Walgreens class action go to: https://bespc.com/cases/WBA\n\n<em>American</em> <em>Airlines</em> <em>Group</em> <em>Inc</em>. (NASDAQ: AAL)\n\nClass Period: January 25, 2024 - May 28, 2024\n\nLead Plaintiff Deadline: September 16, 2024\n\nOn May 28, 2024, after the market closed, <em>American</em> <em>Airlines</em> announced that its Chief Commercial Officer was departing.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "On this news, <em>American</em> <em>Airlines</em>’ stock price fell $1.82, or 13.5%, to close at $11.62 per share on May 29, 2024, thereby injuring investors.",
"sentiment": 0.296,
"highlighted_in": "main_text"
},
{
"highlight": "For more information on the <em>American</em> <em>Airlines</em> class action go to: https://bespc.com/cases/AAL\n\nAbout Bragar Eagel & Squire, P.C.:\n\nBragar Eagel & Squire, P.C. is a nationally recognized law firm with offices in New York, California, and South Carolina.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Reminds Investors That Class Action Lawsuits Have Been Filed Against CVS, Walgreens, and <em>American</em> <em>Airlines</em> and Encourages Investors to Contact the Firm",
"sentiment": 0.3182,
"highlighted_in": "title"
}
]
},
{
"symbol": "WGBA34.SA",
"name": "Walgreens Boots Alliance, Inc.",
"exchange": null,
"exchange_long": null,
"country": "br",
"type": "equity",
"industry": "Healthcare",
"match_score": 36.26462,
"sentiment_score": 0,
"highlights": [
{
"highlight": "., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of CVS Health Corporation (NYSE: CVS), <em>Walgreens</em> <em>Boots</em> <em>Alliance</em>, <em>Inc</em>. (NASDAQ: WBA), and American Airlines Group Inc. (NASDAQ: AAL).",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "For more information on the CVS class action go to: https://bespc.com/cases/CVS\n\n<em>Walgreens</em> <em>Boots</em> <em>Alliance</em>, <em>Inc</em>.",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "CVSH34.SA",
"name": "CVS Health Corporation",
"exchange": null,
"exchange_long": null,
"country": "br",
"type": "equity",
"industry": "Healthcare",
"match_score": 22.860348,
"sentiment_score": 0.41355,
"highlights": [
{
"highlight": "., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of <em>CVS</em> <em>Health</em> <em>Corporation</em> (NYSE: CVS), Walgreens Boots Alliance, Inc. (NASDAQ: WBA), and American Airlines Group Inc. (NASDAQ: AAL).",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>CVS</em> <em>Health</em> <em>Corporation</em> (NYSE: CVS)\n\nClass Period: May 3, 2023 - April 30, 2024\n\nLead Plaintiff Deadline: September 10, 2024\n\nCVS is a healthcare company that operates through three primary segments: Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness.",
"sentiment": 0.8271,
"highlighted_in": "main_text"
}
]
}
]
},
{
"uuid": "b299e5e9-5ef5-4d1f-ba80-98c3a9d7c1fd",
"title": "SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against CAE Inc. – CAE",
"description": "NEW YORK, July 26, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against CAE Inc. (“CAE” or the...",
"keywords": "Pomerantz LLP, Class Action",
"snippet": "NEW YORK, July 26, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against CAE Inc. (“CAE” or the “Company”)...",
"url": "https://www.globenewswire.com/news-release/2024/07/26/2919820/1087/en/SHAREHOLDER-ALERT-Pomerantz-Law-Firm-Announces-the-Filing-of-a-Class-Action-Against-CAE-Inc-CAE.html",
"image_url": "https://www.globenewswire.com/Content/logo/favicon.ico",
"language": "en",
"published_at": "2024-07-26T18:19:00.000000Z",
"source": "globenewswire.com",
"relevance_score": null,
"entities": [
{
"symbol": "CAE",
"name": "CAE Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Industrials",
"match_score": 49.518513,
"sentiment_score": 0.11015,
"highlights": [
{
"highlight": "NEW YORK, July 26, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against <em>CAE</em> <em>Inc</em>. (“CAE” or the “Company”) (<em>NYSE</em>: <em>CAE</em>). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980.",
"sentiment": -0.2263,
"highlighted_in": "main_text"
},
{
"highlight": "SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against <em>CAE</em> <em>Inc</em>. – CAE",
"sentiment": 0.4466,
"highlighted_in": "title"
}
]
},
{
"symbol": "CAE.TO",
"name": "CAE Inc.",
"exchange": null,
"exchange_long": null,
"country": "ca",
"type": "equity",
"industry": "Industrials",
"match_score": 65.798706,
"sentiment_score": 0.13725,
"highlights": [
{
"highlight": "NEW YORK, July 26, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against <em>CAE</em> <em>Inc</em>. (“<em>CAE</em>” or the “Company”) (NYSE: <em>CAE</em>). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980.",
"sentiment": -0.2263,
"highlighted_in": "main_text"
},
{
"highlight": "The class action concerns whether <em>CAE</em> and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.",
"sentiment": 0.296,
"highlighted_in": "main_text"
},
{
"highlight": "You have until September 16, 2024 , to ask the Court to appoint you as Lead Plaintiff for the class if you are a shareholder who purchased or otherwise acquired <em>CAE</em> securities during the Class Period. A copy of the Complaint can be obtained at www.pomerantzlaw.com .",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "[Click here for information about joining the class action]\n\nOn November 14, 2023, <em>CAE</em> issued a press release reporting its second quarter fiscal year 2024 results and stated that certain of the Company’s legacy contracts continued to be plagued by cost overruns.",
"sentiment": 0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "<em>CAE</em> revealed that, within its Defense and Security (“Defense”) segment, the Company planned to “retir[e] legacy contracts, which have been most affected by inflationary pressures” and further stated that “[w]e are firmly focused on retiring legacy contracts as soon as possible and to mitigating the cost pressures associated with them.”",
"sentiment": 0.3262,
"highlighted_in": "main_text"
},
{
"highlight": "Then, on February 14, 2024, <em>CAE</em> issued a press release reporting its third quarter fiscal year 2024 results and identified “eight distinct legacy contracts” that are firm, fixed-price in structure and that suffered from severe cost overruns due to supply chain disruptions, inflationary pressures, and availability of labor.",
"sentiment": -0.8591,
"highlighted_in": "main_text"
},
{
"highlight": "<em>CAE</em> further revealed that “[a]lthough [the contracts] represent only a small fraction of the current business, these contracts have disproportionately impacted overall Defense profitability.”\n\nOn this news, CAE’s stock price fell $2.01 per share, or nearly 10%, to close at $18.91 per share on February 14, 2024.",
"sentiment": 0.5994,
"highlighted_in": "main_text"
},
{
"highlight": "Finally, after the close of trading on May 21, 2024, <em>CAE</em> issued a press release announcing a “re-baselining of its Defense business, Defense impairments, accelerated risk recognition on Legacy Contracts and appointment of Nick Leontidis as COO[.]”",
"sentiment": -0.0258,
"highlighted_in": "main_text"
},
{
"highlight": "The Company stated that “<em>CAE</em> has recorded a $568.0 million non-cash impairment of Defense goodwill,” “$90.3 million in unfavorable Defense contract profit adjustments as a result of accelerated risk recognition on the Legacy Contracts,” and a “$35.7 million impairment of related technology and other non-financial assets which are principally related",
"sentiment": 0.5423,
"highlighted_in": "main_text"
},
{
"highlight": "SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against <em>CAE</em> <em>Inc</em>. – <em>CAE</em>",
"sentiment": 0.4466,
"highlighted_in": "title"
}
]
},
{
"symbol": "CAEN.MX",
"name": "CAE Inc.",
"exchange": null,
"exchange_long": null,
"country": "mx",
"type": "equity",
"industry": "N/A",
"match_score": 65.79774,
"sentiment_score": 0.13725,
"highlights": [
{
"highlight": "NEW YORK, July 26, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against <em>CAE</em> <em>Inc</em>. (“<em>CAE</em>” or the “Company”) (NYSE: <em>CAE</em>). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980.",
"sentiment": -0.2263,
"highlighted_in": "main_text"
},
{
"highlight": "The class action concerns whether <em>CAE</em> and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.",
"sentiment": 0.296,
"highlighted_in": "main_text"
},
{
"highlight": "You have until September 16, 2024 , to ask the Court to appoint you as Lead Plaintiff for the class if you are a shareholder who purchased or otherwise acquired <em>CAE</em> securities during the Class Period. A copy of the Complaint can be obtained at www.pomerantzlaw.com .",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "[Click here for information about joining the class action]\n\nOn November 14, 2023, <em>CAE</em> issued a press release reporting its second quarter fiscal year 2024 results and stated that certain of the Company’s legacy contracts continued to be plagued by cost overruns.",
"sentiment": 0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "<em>CAE</em> revealed that, within its Defense and Security (“Defense”) segment, the Company planned to “retir[e] legacy contracts, which have been most affected by inflationary pressures” and further stated that “[w]e are firmly focused on retiring legacy contracts as soon as possible and to mitigating the cost pressures associated with them.”",
"sentiment": 0.3262,
"highlighted_in": "main_text"
},
{
"highlight": "Then, on February 14, 2024, <em>CAE</em> issued a press release reporting its third quarter fiscal year 2024 results and identified “eight distinct legacy contracts” that are firm, fixed-price in structure and that suffered from severe cost overruns due to supply chain disruptions, inflationary pressures, and availability of labor.",
"sentiment": -0.8591,
"highlighted_in": "main_text"
},
{
"highlight": "<em>CAE</em> further revealed that “[a]lthough [the contracts] represent only a small fraction of the current business, these contracts have disproportionately impacted overall Defense profitability.”\n\nOn this news, CAE’s stock price fell $2.01 per share, or nearly 10%, to close at $18.91 per share on February 14, 2024.",
"sentiment": 0.5994,
"highlighted_in": "main_text"
},
{
"highlight": "Finally, after the close of trading on May 21, 2024, <em>CAE</em> issued a press release announcing a “re-baselining of its Defense business, Defense impairments, accelerated risk recognition on Legacy Contracts and appointment of Nick Leontidis as COO[.]”",
"sentiment": -0.0258,
"highlighted_in": "main_text"
},
{
"highlight": "The Company stated that “<em>CAE</em> has recorded a $568.0 million non-cash impairment of Defense goodwill,” “$90.3 million in unfavorable Defense contract profit adjustments as a result of accelerated risk recognition on the Legacy Contracts,” and a “$35.7 million impairment of related technology and other non-financial assets which are principally related",
"sentiment": 0.5423,
"highlighted_in": "main_text"
},
{
"highlight": "SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against <em>CAE</em> <em>Inc</em>. – <em>CAE</em>",
"sentiment": 0.4466,
"highlighted_in": "title"
}
]
}
]
},
{
"uuid": "d7ab322c-6bb1-455f-bd72-5d0a037bbd91",
"title": "SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against MongoDB, Inc. – MDB",
"description": "NEW YORK, July 26, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against MongoDB, Inc. (“MongoDB” or the...",
"keywords": "Pomerantz LLP, Class Action",
"snippet": "NEW YORK, July 26, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against MongoDB, Inc. (“MongoDB” or the “Co...",
"url": "https://www.globenewswire.com/news-release/2024/07/26/2919817/1087/en/SHAREHOLDER-ALERT-Pomerantz-Law-Firm-Announces-the-Filing-of-a-Class-Action-Against-MongoDB-Inc-MDB.html",
"image_url": "https://www.globenewswire.com/Content/logo/favicon.ico",
"language": "en",
"published_at": "2024-07-26T18:13:00.000000Z",
"source": "globenewswire.com",
"relevance_score": null,
"entities": [
{
"symbol": "MDB",
"name": "MongoDB, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Technology",
"match_score": 85.39963,
"sentiment_score": 0.323863,
"highlights": [
{
"highlight": "NEW YORK, July 26, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against <em>MongoDB</em>, <em>Inc</em>. (“<em>MongoDB</em>” or the “Company”) (<em>NASDAQ</em>: <em>MDB</em>). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980.",
"sentiment": -0.2263,
"highlighted_in": "main_text"
},
{
"highlight": "The class action concerns whether <em>MongoDB</em> and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.",
"sentiment": 0.296,
"highlighted_in": "main_text"
},
{
"highlight": "You have until September 9, 2024 , to ask the Court to appoint you as Lead Plaintiff for the class if you are a shareholder who purchased or otherwise acquired <em>MongoDB</em> securities during the Class Period. A copy of the Complaint can be obtained at www.pomerantzlaw.com .",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "[Click here for information about joining the class action]\n\nOn March 7, 2024, <em>MongoDB</em> issued a press release announcing its fiscal year 2024 earnings and held a related earnings call that same day.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Among other items, <em>MongoDB</em> announced an anticipated near-zero revenue from unused commitments for the Company’s <em>MongoDB</em> Atlas platform in fiscal year 2025, a decrease of approximately $40 million in revenue, attributed to the Company’s decision to change their sales incentive structure to reduce enrollment.",
"sentiment": 0.4588,
"highlighted_in": "main_text"
},
{
"highlight": "Additionally, <em>MongoDB</em> projected only 14% growth for fiscal year 2025, compared to projected 16% growth for the previous year, which had resulted in an actualized 31% growth.\n\nOn this news, MongoDB’s stock price fell $28.59 per share, or 6.94%, to close at $383.42 per share on March 8, 2024.",
"sentiment": 0.8807,
"highlighted_in": "main_text"
},
{
"highlight": "Then, on May 30, 2024, <em>MongoDB</em> again announced significantly reduced growth projections for fiscal year 2025. The Company attributed the reduction to its decision to change its sales incentive structure to reduce enrollment frictions, as well as purportedly unanticipated macroeconomic headwinds.",
"sentiment": 0.7351,
"highlighted_in": "main_text"
},
{
"highlight": "SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against <em>MongoDB</em>, <em>Inc</em>. – MDB",
"sentiment": 0.4466,
"highlighted_in": "title"
}
]
},
{
"symbol": "MDB.MX",
"name": "MongoDB, Inc.",
"exchange": null,
"exchange_long": null,
"country": "mx",
"type": "equity",
"industry": "Technology",
"match_score": 69.65636,
"sentiment_score": 0.323863,
"highlights": [
{
"highlight": "NEW YORK, July 26, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against <em>MongoDB</em>, <em>Inc</em>. (“<em>MongoDB</em>” or the “Company”) (NASDAQ: MDB). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980.",
"sentiment": -0.2263,
"highlighted_in": "main_text"
},
{
"highlight": "The class action concerns whether <em>MongoDB</em> and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.",
"sentiment": 0.296,
"highlighted_in": "main_text"
},
{
"highlight": "You have until September 9, 2024 , to ask the Court to appoint you as Lead Plaintiff for the class if you are a shareholder who purchased or otherwise acquired <em>MongoDB</em> securities during the Class Period. A copy of the Complaint can be obtained at www.pomerantzlaw.com .",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "[Click here for information about joining the class action]\n\nOn March 7, 2024, <em>MongoDB</em> issued a press release announcing its fiscal year 2024 earnings and held a related earnings call that same day.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Among other items, <em>MongoDB</em> announced an anticipated near-zero revenue from unused commitments for the Company’s <em>MongoDB</em> Atlas platform in fiscal year 2025, a decrease of approximately $40 million in revenue, attributed to the Company’s decision to change their sales incentive structure to reduce enrollment.",
"sentiment": 0.4588,
"highlighted_in": "main_text"
},
{
"highlight": "Additionally, <em>MongoDB</em> projected only 14% growth for fiscal year 2025, compared to projected 16% growth for the previous year, which had resulted in an actualized 31% growth.\n\nOn this news, MongoDB’s stock price fell $28.59 per share, or 6.94%, to close at $383.42 per share on March 8, 2024.",
"sentiment": 0.8807,
"highlighted_in": "main_text"
},
{
"highlight": "Then, on May 30, 2024, <em>MongoDB</em> again announced significantly reduced growth projections for fiscal year 2025. The Company attributed the reduction to its decision to change its sales incentive structure to reduce enrollment frictions, as well as purportedly unanticipated macroeconomic headwinds.",
"sentiment": 0.7351,
"highlighted_in": "main_text"
},
{
"highlight": "SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against <em>MongoDB</em>, <em>Inc</em>. – MDB",
"sentiment": 0.4466,
"highlighted_in": "title"
}
]
},
{
"symbol": "0KKZ.L",
"name": "MongoDB, Inc.",
"exchange": null,
"exchange_long": null,
"country": "gb",
"type": "equity",
"industry": "N/A",
"match_score": 69.654175,
"sentiment_score": 0.323863,
"highlights": [
{
"highlight": "NEW YORK, July 26, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against <em>MongoDB</em>, <em>Inc</em>. (“<em>MongoDB</em>” or the “Company”) (NASDAQ: MDB). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980.",
"sentiment": -0.2263,
"highlighted_in": "main_text"
},
{
"highlight": "The class action concerns whether <em>MongoDB</em> and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.",
"sentiment": 0.296,
"highlighted_in": "main_text"
},
{
"highlight": "You have until September 9, 2024 , to ask the Court to appoint you as Lead Plaintiff for the class if you are a shareholder who purchased or otherwise acquired <em>MongoDB</em> securities during the Class Period. A copy of the Complaint can be obtained at www.pomerantzlaw.com .",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "[Click here for information about joining the class action]\n\nOn March 7, 2024, <em>MongoDB</em> issued a press release announcing its fiscal year 2024 earnings and held a related earnings call that same day.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Among other items, <em>MongoDB</em> announced an anticipated near-zero revenue from unused commitments for the Company’s <em>MongoDB</em> Atlas platform in fiscal year 2025, a decrease of approximately $40 million in revenue, attributed to the Company’s decision to change their sales incentive structure to reduce enrollment.",
"sentiment": 0.4588,
"highlighted_in": "main_text"
},
{
"highlight": "Additionally, <em>MongoDB</em> projected only 14% growth for fiscal year 2025, compared to projected 16% growth for the previous year, which had resulted in an actualized 31% growth.\n\nOn this news, MongoDB’s stock price fell $28.59 per share, or 6.94%, to close at $383.42 per share on March 8, 2024.",
"sentiment": 0.8807,
"highlighted_in": "main_text"
},
{
"highlight": "Then, on May 30, 2024, <em>MongoDB</em> again announced significantly reduced growth projections for fiscal year 2025. The Company attributed the reduction to its decision to change its sales incentive structure to reduce enrollment frictions, as well as purportedly unanticipated macroeconomic headwinds.",
"sentiment": 0.7351,
"highlighted_in": "main_text"
},
{
"highlight": "SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against <em>MongoDB</em>, <em>Inc</em>. – MDB",
"sentiment": 0.4466,
"highlighted_in": "title"
}
]
},
{
"symbol": "M1DB34.SA",
"name": "MongoDB, Inc.",
"exchange": null,
"exchange_long": null,
"country": "br",
"type": "equity",
"industry": "Technology",
"match_score": 69.65378,
"sentiment_score": 0.323863,
"highlights": [
{
"highlight": "NEW YORK, July 26, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against <em>MongoDB</em>, <em>Inc</em>. (“<em>MongoDB</em>” or the “Company”) (NASDAQ: MDB). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980.",
"sentiment": -0.2263,
"highlighted_in": "main_text"
},
{
"highlight": "The class action concerns whether <em>MongoDB</em> and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.",
"sentiment": 0.296,
"highlighted_in": "main_text"
},
{
"highlight": "You have until September 9, 2024 , to ask the Court to appoint you as Lead Plaintiff for the class if you are a shareholder who purchased or otherwise acquired <em>MongoDB</em> securities during the Class Period. A copy of the Complaint can be obtained at www.pomerantzlaw.com .",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "[Click here for information about joining the class action]\n\nOn March 7, 2024, <em>MongoDB</em> issued a press release announcing its fiscal year 2024 earnings and held a related earnings call that same day.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Among other items, <em>MongoDB</em> announced an anticipated near-zero revenue from unused commitments for the Company’s <em>MongoDB</em> Atlas platform in fiscal year 2025, a decrease of approximately $40 million in revenue, attributed to the Company’s decision to change their sales incentive structure to reduce enrollment.",
"sentiment": 0.4588,
"highlighted_in": "main_text"
},
{
"highlight": "Additionally, <em>MongoDB</em> projected only 14% growth for fiscal year 2025, compared to projected 16% growth for the previous year, which had resulted in an actualized 31% growth.\n\nOn this news, MongoDB’s stock price fell $28.59 per share, or 6.94%, to close at $383.42 per share on March 8, 2024.",
"sentiment": 0.8807,
"highlighted_in": "main_text"
},
{
"highlight": "Then, on May 30, 2024, <em>MongoDB</em> again announced significantly reduced growth projections for fiscal year 2025. The Company attributed the reduction to its decision to change its sales incentive structure to reduce enrollment frictions, as well as purportedly unanticipated macroeconomic headwinds.",
"sentiment": 0.7351,
"highlighted_in": "main_text"
},
{
"highlight": "SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against <em>MongoDB</em>, <em>Inc</em>. – MDB",
"sentiment": 0.4466,
"highlighted_in": "title"
}
]
}
]
}
]
}
]
}
Sentiment
Live response for past 24 hours
{
"meta": {
"returned": 1,
"limit": 10
},
"data": [
{
"key": "mx",
"total_documents": 802,
"sentiment_avg": 0.28468764181564415
}
]
}
Other details
Entity count
- 5,433